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ABSTRACT 
There is an increasing number of people with neurological conditions. These people are 
living longer due to advances in critical care medicine and increasing survival and life 
expectancy rates among an aging population. As a result, neurological conditions and their 
attendant disabilities impact over 3.7 million people living in Canada and account for large 
health care expenditures, both by the publicly funded health system and through out-of-pocket 
payments by individuals with the conditions. Our main objective is to discover, other factors 
besides age, that affect the quality of life for Canadians living with neurological conditions. We 
use nationally representative population based survey data to identify risk factors, trends, health 
care and general life satisfaction for select neurological conditions found among Canadians. In 
order to inform health systems planning and direction of financial resources, policy and services, 
especially amidst grim predictions on the overall burden of these conditions on the Canadian 
economy, we examine specific neurological conditions (Alzheimer’s disease (AD)/dementia, 
Parkinson’s disease (PD), stroke effects, migraine headaches, multiple sclerosis (MS), cerebral 
palsy, epilepsy, amyotrophic lateral sclerosis (ALS), Huntington's disease, Tourette’s syndrome, 
dystonia, muscular dystrophy, hydrocephalus, spina bifida, brain and spinal cord tumors, and 
brain and spinal cord injuries), either independently or collectively in four distinct studies.  
In the first study, chapter 3, we confirmed through our systematic review and meta-
analysis that toxic occupational exposures are significant risk factors for the development of 
Parkinson’s disease especially that confirmed by a neurologist or nurse using standardized 
diagnostic methodology. 
The second study analyzed the trends in AD/dementia prevalence by age, gender, 
education and geographic regions and found increasing prevalence across all strata of the 
community, with more men than women living with AD/dementia in the community. Increases 
in prevalence over the twenty-year period were less among those with higher levels of education 
and in the 45-64 age category, while prevalence was higher in the 65-79 age category and 
ballooned in the 80+ age categories of both men and women. 
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The third study assessed the relationship between self-reported unmet care needs and 
general health care satisfaction, satisfaction with physician and satisfaction with hospital services 
among Canadians with neurological conditions. We found that patient satisfaction was positively 
influenced by quality and availability of provincial and received care and being satisfied with life 
in general while unmet health care needs and receiving emergency services at the hospital had a 
negative impact on patient satisfaction. 
The final study which examined the association between spirituality/religiosity and 
general life satisfaction among Canadians with neurological conditions found a protective 
relationship between spiritual values providing strength to face everyday difficulties, regular 
attendance at religious services and self-perceived physical and mental health and satisfaction 
with life in general.  
The final take-home messages from our findings is that a population-based approach and 
a coordinated holistic system of care are needed for primary prevention of neurological 
conditions and the enhanced quality of life among the patients.  
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CHAPTER 1 – INTRODUCTION 
1.1 The impact of neurological conditions  
Neurological conditions are a major contributor to disability in the Canadian population. 
Approximately 3.77 million Canadians live with neurological conditions. Of this number, 
170,000 are cared for in institutions (1). Most neurological conditions are long term, meaning 
they develop from injury or impairment to the nervous system, resulting in life long impacts (2, 
3). These conditions, many of which are incurable and worsen overtime, are associated with 
symptoms and functional impairments that are daily challenges to individuals and their families 
(4). These challenges which include and are not limited to impaired cognition i.e., memory and 
capacity to think; paralysis or weakened muscles; loss of coordination and sensation; pain; 
seizures and confusion; have life-altering effects for individuals with the conditions (1, 4, 5).  
Some neurological conditions are reported to have shared risk factors such as inherited 
biological characteristics (sex, age, genetic susceptibility), exposure to environmental and 
occupational toxins, and lifestyle choices (smoking, nutritional choices, alcohol consumption), 
social characteristics such as socio-economic status, cultural effects of ethnic backgrounds which 
may overlap with biological and behavioral factors (6). Shared risk factors for the more common 
neurological conditions, Parkinson’s disease (PD) and Alzheimer’s disease/dementia (AD), 
include genetics or family history, sex, head trauma, lower levels of education and exposure to 
environmental toxins (6-11). Smoking, hypertension, and high cholesterol (7, 12, 13) seem to 
increase the risk of AD/dementia while midlife adiposity, regular infections, and dietary 
practices including high animal fat intake have been reported to be linked to increased risk of PD 
(7, 8, 14).  
Age has also been identified as a common risk factor for many of the other neurological 
conditions impacting Canadians. Neurological conditions are more common in the older 
population, impacting 5% to 55% of people 55+ years of age (15-17). Among adults aged 60 and 
over in all regions of the world, there is a rapidly rising risk of death with those 60 years of age 
having a 55% odds of dying before they reach 70 years old (15). By 2031, Canada’s population 
is expected to grow to more than 40 million people with a shift in the age structure resulting in 
increased numbers of Canadian 65 years and older (4). This shift in population age structure is 
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attendant with an increase in incidence of some of the more common neurological conditions 
such as AD/dementia and PD due to their significantly increased incidence among those over the 
age of 65 years (5), thereby contributing to an increased prevalence.  
Through microsimulation modelling, it is projected that the total number of cases of 
AD/dementia will increase from 340,000 in 2011 to 674,000 in 2031, accounting for 334,000 
new cases and a 5-year delayed age-specific incidence of 1.10 per 1,000 people, relative to 
baseline incidence rates. A further 1.13 per 1,000 incidence rate is projected among males and 
1.07 per 1,000 people among females. In other words, the total number of cases of AD/dementia 
in males will increase from 142,000 in 2011 to 291,000 in 2031, and 198,000 to 383,000 in 
females over the same period (18).  
Pringsheim, Fiest, and Jette, 2014, list the global incidence of Parkinson’s disease in 65+ 
individuals as 36.5 per 100,000 person-years among males and 65.5 per 100,000 person-years 
among females (19). They also state that the pooled worldwide community-based prevalence of 
dementias including AD/dementia in 65+ individuals was 4.63 % and the region-specific 
community-based prevalence among those 65+ in North America was approximately 6.0% (19). 
They list the worldwide prevalence for the more common neurological conditions in Canada as 
follows: Tourette syndrome, 0.77%; Epilepsy, 5.96% (0.68% North American); PD, 0.32% 
(female 0.04% and male 0.07%); cerebral palsy, 0.22%; traumatic brain injury, 0.21% (0.17% 
North American); hydrocephalus, 0.14%; spina bifida, 0.05% (0.04% North American); brain 
tumors, 0.01%; dystonia, 0.005%; muscular dystrophy, 0.005%; spinal cord injury (SCI), 
0.003% (0.004% North American); and Huntington’s disease, 0.003% (19). 
Similar to their range of prevalence and conditions, the overall burden of neurological 
conditions is increasingly multifaceted and transcends the health system. Because they are linked 
to a high risk of negative health outcomes, including mortality, disability, falls, 
institutionalization and hospitalization, they have a considerable impact, not only on those living 
with the conditions, but also their families, caregivers and employers (15, 20, 21). Neurological 
conditions present a huge financial burden globally and in 2016 was the major cause of 
worldwide disability adjusted life years (DALYs) (22). Furthermore, the economic impact of 
neurological conditions on Canada is great, due to direct health care expenditures (hospital care, 
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physician care and drugs) and indirect costs such as death, long-term disability, and lost 
productivity (4, 23). The total pooled cost of neurological conditions including AD/dementia, 
PD, multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), brain tumors, epilepsy, 
migraine headaches, cerebral palsy, head injury, spinal cord injuries (SCI) and stroke effects (24) 
was estimated in 2007 to be $8.8 billion, which represented what would be 4.6% of the total 
attributable cost of illness ($192.8 billion) in Canada in 2008 (4, 5).  
More recent estimates suggest that the annual total direct health care costs were higher 
among individuals with neurological conditions than those without those conditions. In 2014, the 
total direct health care costs estimated for Alzheimer’s disease and other dementias was 
$527,494,000. Other estimated total direct health care costs included $208,679,000 for epilepsy, 
$120,358,000 for PD, and $17,720,000 for spinal cord injury (1). It is projected that by 2031, the 
total indirect economic cost, combining loss due to working-age premature death and disability 
for each neurological condition, will increase. This cost, depending upon the neurological 
condition, will range from $0.3 billion to $8.2 billion (1). The burdens of living with 
neurological conditions are not confined to the impacts on a country’s economy. Those living 
with neurological conditions also face many challenges associated with disabilities that result 
from long term neurological conditions.  
A major challenge common across people with neurological conditions is psychosocial 
difficulties, defined as deficiencies in mental and body functions under central nervous system 
control that result in activity limitations and participation restrictions (25, 26). Challenges with 
independent living, relationships, social interaction and occupations are examples of 
psychosocial difficulties that occur across neurological conditions (27). Common determinants 
of these challenges have been identified as approaches and care of health professionals, caregiver 
(usually family) attitudes and the availability of help and assistance (25). Impairments and 
psychosocial difficulties may significantly influence the physical and mental health, subsequent 
care and quality of life associated with neurological conditions (28). People with psychosocial 
difficulties, common to neurological conditions, have reported higher numbers of unmet health 
care needs (29-31) that may go unnoticed by health professionals (32).  
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Indeed, patients with select neurological conditions have identified that their greatest 
need is access to health care services that maintain relevance as their diseases progress (33-35). 
Access to such care influences health care utilization, patient satisfaction and quality of life (36). 
Quality health care access is influenced by four major factors: structural issues, which may be 
influenced by age and education; patient perception concerns, i.e., patient satisfaction with 
quality and availability of care; having access to regular source of care and emergency service 
use (health care utilization); and health outcomes such as self-perceived physical and mental 
health (37). Obstruction of any of the aforementioned four factors results in unmet health care 
needs (33, 38) and reduced quality of life.  
Quality of life, as defined by the World Health Organization (WHO) is “an individual's 
perception of their position in life in the context of the culture and value systems in which they 
live and in relation to their goals, expectations, standards and concerns” (38). Quality of life is a 
broad concept and is impacted by the complex interplay among physical health, psychological 
well-being, personal beliefs, social relationships and their relationship to environmental factors 
(39). In keeping with that definition, activity and participation in social and lifestyle activities, 
and the ability to cope have been established as predictors of quality of life among those with 
neurological conditions (40).  
On the other hand, life satisfaction is a concept related to quality of life and is a 
subjective measure of one’s quality of life as a whole (41, 42). Buetell, 2006, further explains life 
satisfaction as the “overall assessment of feelings and attitudes about one’s life at a particular 
point in time ranging from negative to positive” (43). In this thesis, we view life satisfaction as 
an individual’s measure of quality of life at a particular point in time. Spirituality has been 
demonstrated as a coping mechanism while living with neurological conditions. At points in 
time, it has provided meaning and sense to catastrophic life events, allowing individuals to find 
purpose to life circumstances, and experience increased life satisfaction amidst adversities (44). 
The available knowledge and expertise regarding neurological conditions are as varied as 
each separate condition. However, the substantial and sometimes calamitous nature of the 
diseases have large scale impacts on those with neurological conditions, their families and care 
providers. The needs and gaps are far reaching in their effects and overlie physical and mental 
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health. Though treatment mechanisms for each neurological condition may be different, the 
management of care for each in Canada is dependent upon the same intricate, complex and 
multifaceted designs of health and social services (45). As a result, a number of health regions 
across Canada have adopted best practices that incorporate the fundamental philosophies of the 
Expanded Chronic Care Model (45-47) to address psychosocial as well as physiological needs 
for improved outcomes across chronic conditions (46).  
The Expanded Chronic Care Model incorporates population health promotion and 
prevention into the management of chronic disease. It seeks to decrease the burden of chronic 
disease, by reducing the impact on those who have a disease and also supporting people and 
communities to be healthy (46). This model of care is important to the concepts examined in this 
thesis in relation to Canadian living with neurological condition. An integrated approach to the 
development of policies and public health prevention solutions for the management of 
neurological conditions as a whole, mirroring that of the Expanded Chronic Care Model is 
necessary to reduce the burdens to families, health systems and the economy, associated with 
these conditions. 
1.2 The context of this research 
More people are living longer with neurological conditions due to advances in critical 
care medicine and increasing survival and life expectancy rates among an aging population 
(48, 49). This means that there is an increase in the number of aging persons living with the 
debilitating impacts of neurological conditions including multiple disabilities (50) and a range 
of physical, social, and psychological complications (51, 52). As a consequence, these 
individuals require services and care such as timely information, support and rehabilitation, 
and may need the usage of assistive devices and appliances (52). There is evidence in the 
literature to suggest that, despite these needs, people with neurological conditions continue to 
experience poorer health and are at greater risk of developing secondary health 
problems and report unmet needs as well as barriers and delays in receiving the care and services 
that they require (48). These unmet health care needs, coupled with the progressive and lifelong 
nature of most of these conditions may have a significant effect on healthcare utilization (4, 
49).  
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In addition, unmet health care needs reduce quality of life of both patients and 
caregivers (52) and have been associated with decreased patient satisfaction with healthcare 
services (53, 54). Patient satisfaction has been demonstrated as an indicator of quality of care, 
which in turn has an impact on quality of life. While there is much more information on unmet 
health care needs, health care utilization, patient satisfaction and their effects on quality of life 
for other chronic conditions or select neurological conditions, there is a gap in the literature of 
Canadian studies on neurological conditions as a group (as is necessary for the assessment of a 
chronic care model). Principles of self-management are emphasized in the expanded chronic 
care model. This model of care, which takes into consideration psychological outcomes such as 
positive coping, has an impact on quality of life for those living with chronic conditions (55). 
Quality of life is enhanced among those with spirituality and/or religious faith (56). For those 
for whom it is relevant, spirituality and religious faith are important coping resources for living 
with chronic conditions. Even among the more secular societies, spirituality and religious faith 
have been reported to provide emotional well-being, preserve self‐esteem, and lead to a better 
tolerance of pain and other symptoms (57-60). However, most studies on neurological conditions 
have focused mainly on links between spirituality and physical health, with fewer studies on 
neurological conditions measuring the influence of spirituality on indicators of psychological 
functioning, such as life satisfaction (1). 
Despite the expected rise in incidence of neurological conditions and associated health 
care costs and caregiver burdens, there is a lack of studies highlighting recent trends in 
prevalence of the more common conditions. For example, recent trend data is lacking for 
AD/dementia in Canada by age, gender, education and regions. Such knowledge is important for 
informed health systems planning and direction of financial resources and services, especially 
amidst grim predictions on the overall burden of these conditions on the Canadian economy. In 
relation to estimates of incidence and prevalence of neurological conditions in Canada, only one 
study identified provided data for all provinces and territories (61, 62). Although prevalence 
estimates exist, they may not be applicable to all Canadian jurisdictions.  
Notwithstanding the abundance of information on risk factors, health care utilization and 
economic burden, this information does not thoroughly explain the impact on the quality of life 
measures associated with living with neurological conditions (23) among Canadians, especially 
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those in the 65+ age categories. As well, there are unique effects of neurological conditions 
related to spiritual needs (62) and unmet healthcare needs that impact health care and general life 
satisfaction, that are not widely described in the literature.  
The predominant theme of this research is to examine, in addition to age, what other 
factors affect the quality of life for Canadians living with neurological conditions. In this 
research, we conduct a systematic review of the literature and examine population based survey 
data, which is nationally representative, to identify risk factors, trends, health care and general 
life satisfaction for select neurological conditions found among Canadians. This thesis focuses 
on reducing the existing gaps in research on the experiences of Canadians living with select 
neurological conditions. We examine specific neurological conditions [AD/dementia, PD, stroke 
effects, migraine headaches, MS, cerebral palsy, epilepsy, ALS, Huntington's disease, Tourette’s 
syndrome, dystonia, muscular dystrophy, hydrocephalus, spina bifida, brain and spinal cord 
tumors, and brain and SCI (62)], either independently or collectively in specific studies, 
depending on the availability of data and the need to protect confidentiality while retaining large 
enough sample sizes to maintain study power. This thesis is composed of four substantive 
chapters that: 
 Conduct a systematic review and meta-analysis of existing literature examining the 
association between toxic occupational exposures and PD using longitudinal studies. 
 Analyze the trends in AD/dementia prevalence by age, sex, education and geographic 
regions using data from national Canadian health surveys. 
 Assess the relationship between self-reported unmet care needs and (1) general health 
care satisfaction, (2) satisfaction with physician and (3) satisfaction with hospital services 
among Canadians with neurological conditions 
 Examine the effects of sociodemographic factors, physical and mental health and 
spirituality on general life satisfaction (GLS) in Canadians with neurological conditions, 
using data from the Canadian Community Health Survey. 
The major chapters in this thesis are linked by (1) the commonalities of the neurological 
conditions studied, (2) the fact that these conditions together account for a huge burden to the 
health system, the Canadian economy and the society and, (3) neurological conditions get 
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progressively worse over time and are accompanied by psychosocial difficulties. It is anticipated 
that the major chapters of this thesis will contribute to the ongoing dialogue about how the 
government of Canada as a whole and particularly the health ministries and services can better 
meet the specific health needs of an aging population, who by nature of being, will continue to 
be impacted by select chronic neurological conditions.  
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CHAPTER 2 – METHODS AND PROCEDURES 
2.1 Study designs 
In this thesis, two study designs and various epidemiological methods are employed in 
the assessment of secondary survey data and a review of existing literature. It is comprised of 
four major studies, each separate and independent, and a closing chapter on the general 
implications for program and policy development and future research that may need to be 
undertaken.  
In Chapter 3, a systematic review and meta-analysis is conducted.  This review of 
longitudinal studies was done using the Preferred Reporting Items for Systematic Reviews and 
Meta-analysis (PRISMA) guidelines (1). This study design is advantageous in that most sources 
of bias and heterogeneity can be statistically examined while measuring the sensitivity of 
statistically significant results. It presents reliable estimates of the impacts of exposures or 
interventions, so that robust inferences can be made. (2). Thus, representing the strongest source 
of evidence for policy makers and health systems to keep abreast of comprehensive solutions to 
questions or challenges. Noteworthy limitations are loss of information on essential outcomes, 
potential publication bias, heterogeneity, and the combination of evidence from a combination of 
studies. Because the quality of these studies may vary, care has to be taken in the interpretation 
of the results as they may not be generalizable to entire populations, and may be more suitable to 
subsets of people within a population (2). Due to the variability of the quality of systematic 
reviews, readers are limited in their ability to assess strengths and weaknesses of the reviews (3).   
Cross-sectional study designs are used in Chapters 4, 5 and 6. These study designs were 
employed because they yield information that is representative of the Canadian population. 
While they provide very valuable information on prevalence and associated risk factors, are 
advantageous in that they are relatively inexpensive, are less time-consuming and present the 
opportunity for examining many risk factors and outcomes, cross sectional study designs are 
limited in providing for causal inferences (4). Therefore, the results of analysis using cross-
sectional study designs should be interpreted with caution, because different participants may be 
interviewed at each cross section in time, making it difficult to determine whether changes in 
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prevalence represent a trend or are due to differences between separate groups of survey 
respondents. In addition, in cross-sectional studies, data on independent and dependent variables 
are collected simultaneously, making it impossible to differentiate cause and effect between 
exposure and outcome variables. This violates Bradford Hill’s temporal criterion of causality.  
The cross-sectional surveys used in this thesis employ complex designs. The sample 
design of the NPHS was shaped by a number of factors aimed at improving the precision of 
survey estimates. These included stratified sampling by provinces and cluster sampling within 
the provinces in proportion to their population sizes based on household Census. This type of 
sampling is advantageous because it allows for calculation of descriptive frequencies by 
province, the production of sample weights that allows computation of nationwide estimates of 
parameters (5). 
2.2 Data Sources 
For the systematic review and meta-analysis in Chapter 3, search strategies were used to 
conduct an electronic search for published articles in databases such as Medline/PubMed, 
EMBASE, Toxnet, LILACS, and Cochrane Library. Reference lists in eligible articles and grey 
literature were vetted to find the most comprehensive articles for inclusion in the review. Also, a 
manual search was done on other resources for additional relevant studies. Eligibility of articles 
was determined by established inclusion and exclusion criteria.  
This thesis also includes analyses from Statistics Canada’s cross-sectional data from 
anonymized Master Microdata Files with restricted access through the Saskatchewan Research 
Data Centre (SKY-RDC) and Public Use Microdata Files (PUMF) with free electronic access to 
the public. The anonymized Master microdata files accessible through the Research Data Centre 
(RDC) contain most of the confidential original content collected during the survey period, and 
additional variables derived post data collection, while the publicly accessible, PUMF, limits the 
possibility of identifying individual survey respondents due to the aggregation and removal of 
variables that could be identifying characteristics (6).  
The first 12-month cycle of the National Population Health Survey (NPHS) started in 
June 1994 and it was conducted every other year following. It was designed to provide 
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information to guide health policy and system development and evaluation due to increasing 
financial pressures on the Canadian health system (7). The survey produced both periodic cross-
sectional and longitudinal data including demographic content and modules on health status, 
chronic conditions, health services utilization and determinants of health, among other topics (7).  
The CCHS began in 2000 as a joint initiative of the Canadian Institute of Health 
Information (CIHI), Statistics Canada, Health Canada and the Public Health Agency of Canada. 
Similar to the NPHS, the CCHS provides population-based data on health determinants, health 
care utilization and health status (8). At the onset, the survey was conducted every two years, 
providing data from across the nation, provinces and health regions, until 2007 when this data 
began to be collected annually. The CCHS data is comprised of three major modules: (1) 
common content that is composed of cored and themed information that is asked of all 
participants annually, with some modules from the common content collected for two years and 
alternate between two to four years, (2) optional content that varies year over year, according to 
the information needs of provinces or territories and, (3) Rapid Response content that is 
accessible to organizations who wish to have national estimates on an evolving or particular 
issue connected to the health of the general population (9). 
In chapter 4, our analysis of trends in prevalence across various strata of the Canadian 
community was conducted using the PUMF NPHS 1994-95, 1996-97 and 1998-99 and restricted 
SKY-RDC anonymized master files of the Canadian Community Health Survey-Annual 
Components, 2000-2014.  
In Chapter 5, the restricted SKY-RDC anonymized master file of the CCHS – 2010 was 
used in the multivariate model building process to determine predictors of patient satisfaction. 
The CCHS-2010 was used because the data contained one-year unique common content on 
health care utilization: unmet health care needs (UCN) and neurological conditions (NEU) and 
the optional content on patient satisfaction (10), all of interest in this study. Respondents with 
neurological conditions who received health care services and completed the optional module on 
patient satisfaction as well as the unique common content on unmet health care needs resided in 
the province of Ontario. 
16 
 
Chapter 6 utilized the restricted SKY-RDC anonymized master files of the CCHS - 2011 
to examine predictors of one of the components of quality of life, general life satisfaction. The 
CCHS-2011 anonymized Master Files were used for this study because it is the latest survey 
containing responses on all major variables of interest in this study: common content on general 
life satisfaction, the one-year unique common content on neurological conditions and the 
optional content on spiritual values (11). Respondents with neurological conditions who reported 
on general life satisfaction and completed the optional module on spiritual values resided in the 
provinces of New Brunswick (NB) and Manitoba (MB). 
2.3 Statistical Analysis  
Demographic and clinical characteristics such as age, gender, marital status, educational 
status, income level, etc., of Canadians living with selected neurological conditions , were 
examined through descriptive analysis (Chapter 5 and 6). 
Quantitative meta-analysis was done in the systematic review (Chapter 3). Meta-analysis 
was applied to pool estimates from previous studies to determine the strength of association 
between toxic occupational exposures (electromagnetic, metal and pesticides) and Parkinson’s 
disease. This increases study power in comparison to single, separate studies, allowing for 
measurement of consistency of effect across different samples (12). 
Age and sex standardization of prevalence estimates using the 2001 census data was used 
to calculate prevalence estimates of Alzheimer’s disease/dementia by age, sex, highest level of 
education, and geographical region, over a twenty-year period, from 1994-2014 (Chapter 4).  
Univariate and multivariate logistic regression models were performed for dichotomous 
outcome variables in Chapter 5 and 6. Table 2-1 summarizes the study designs of the individual 
studies included in this thesis. 
Chapters 4, 5, and 6 utilized data from complex surveys. To account for this survey 
design, weighted analysis was completed by applying sampling weights to our data set. In 
consultation, it was decided not to proceed with bootstrapping due to the very small sample size 
of the population for each study.
  
 
1
5 
Table 2- 1 Summary of study designs in this thesis 
Title of Study Study design Method & Analysis Age category of 
participants 
Chapter 3- Toxic Occupational Exposures and their 
Association with Parkinson’s Disease: A systematic 
Review and Meta-Analysis 
 
Meta-analysis Systematic Review 
Meta-Analysis 
16+ years 
Chapter 4- Trends in prevalence of self-reports of 
Alzheimer’s disease/dementia, among 45+ individuals 
in Canada, 1994-2014 
 
Cross-sectional Descriptive analysis 
Trend Analysis 
45+ years 
Chapter 5- Unmet Health Care Needs: Factors 
predicting Satisfaction with Health Care Services 
among Canadians with Neurological Conditions using 
data from the Canadian Community Health Survey, 
Annual Component, 2010 
 
Cross-sectional Descriptive analysis 
Logistic Regression 
12+ 
Chapter 6- An exploration of the sociodemographic 
factors and select measures of spirituality/religiosity 
that predict general life satisfaction among Canadians 
with neurological conditions 
 
Cross-sectional Descriptive analysis 
Logistic Regression 
12+ 
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CHAPTER 3 – TOXIC OCCUPATIONAL EXPOSURES AND THEIR ASSOCIATION WITH 
PARKINSON’S DISEASE: A SYSTEMATIC REVIEW WITH META-ANALYSIS 
 
 
A version of this chapter will be submitted for journal publication review. 
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3.1 Abstract 
Background: Parkinson’s disease (PD) is the second most common age associated 
neurodegenerative condition contributing to a doubling of disease burden from 1990 to 2016. 
Previous epidemiological studies highlight exposure to environmental and occupational toxins as 
significant risk factors for PD. However, most studies have been cross-sectional and are of 
varying quality, utilizing questionnaires or other methods of recall, introducing bias. In this 
study, our aim is to (1) determine the strength of association between overall toxic occupational 
exposures and three types of toxic occupational exposure (metals, electromagnetic and 
pesticides) and the occurrence of Parkinson’s disease and (2) understand the relationship 
between toxic occupational exposures and PD by diagnostic methods. 
Methods: A search was conducted of EMBASE, PubMed/Medline, Toxnet, LILACS, and 
Cochrane Library databases for longitudinal studies which included an assessment of toxic 
occupational exposure, Parkinsonian or related disorders, diagnosed by international 
classification of diseases (ICD) codes, medical records or confirmation by a neurologist or nurse, 
and published in English language for the period January 1990 to March 2019. Pooled relative 
risk (RR) estimates were produced using random effects models. 
Results: Twenty-four articles were used in the analyses. The pooled RR between toxic 
occupational exposures and PD was 1.15 (95% confidence interval (CI) 1.06–1.24), and 1.03 
(95% CI 0.91–1.16) between electromagnetic exposure and PD, while the pooled RR between 
PD and metal and pesticide exposure were 1.07 (95% CI 0.92–1.24) and 1.41 (95% CI 1.20–
1.65), respectively. The pooled RR for methods of diagnosis and their associations with PD 
were: confirmation by a neurologist or nurse, 2.17 (95% CI 1.32-3.54); medical records, 1.06 
(95% CI 0.92-1.21); and ICD codes, 1.14 (95% CI 1.03-1.26).  
Conclusions: Our systematic review provides robust evidence that toxic occupational exposures 
particularly to pesticides are significant risk factors for PD especially that diagnosed by 
neurologists or nurses using standardized methods. This evidence supports the need for (1) 
general prevention efforts targeted to those in occupations that expose them to occupational 
chemicals or toxins and (2) using a reliable standardized approach by a specialist is important for 
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the accurate confirmation of PD and establishing accurate estimates of risk of PD through toxic 
occupational exposures. 
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3.2 Introduction 
Population growth worldwide coupled with increasing life expectancy in current years 
result in more people reaching ages where neurological disorders are most prevalent (1, 2). 
Parkinson’s disease (PD) is one such example, as it is the second most common age associated 
adult neurodegenerative condition, following Alzheimer’s disease (AD)/dementia (3). The 
worldwide burden of the disease more than doubled over 26 years, from 2.5 million patients in 
1990 to 6.1 million patients in 2016. This increase is attributed to longer disease duration, a 
result of living longer with disease, and possible changes in environmental risk factors (4). The 
pathology of PD includes the degeneration of dopaminergic neurons along with the accumulation 
of Lewy bodies in select regions of the central and peripheral nervous system (5). This type of 
neurological involvement in PD results in a progressive movement disorder. Signs of PD involve 
severe motor dysfunction and may include slow movement, postural instability and rigidity, 
resting tremors, anxiety, depression and cognitive decline in tandem with disease progression (6, 
7). 
Epidemiologic studies have highlighted that residing in rural communities, consuming 
well water, farming, and exposure to chemicals, metals, electromagnetic fields were significantly 
associated with PD (6, 8-9). There have been variable results in investigations of occupation as a 
potential risk factor for PD. Some occupations may serve as proxies to harmful exposures to 
environmental factors. For e.g. farming acts as the vehicle to pesticide exposure, while welding 
is the conduit to metal exposures. Therefore, it is the toxic occupational exposures rather than 
particular occupations that have been explored in more recent studies (10) that have been found 
to be associated with Parkinson’s disease.  
There is an abundance of evidence in the literature (11-16) to suggest that toxic 
occupational exposure is strongly linked with Parkinson’s disease. The most common toxic 
occupational exposures in the literature (17) in order of rank have been pesticides (18-20), metals 
(21), and extremely low frequency electromagnetic fields (22). Most studies on pesticide 
exposure suggest a significant association between pesticide use and PD risk, while there have 
been variations in the direction of the association between toxic occupational exposures to metal 
and electromagnetic fields.  
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Most of the review studies that demonstrate a link between toxic occupational exposures 
and Parkinson’s disease have not been rigorous in excluding studies of lower scientific quality or 
those that have not applied the Meta-analysis of Observational Studies in Epidemiology 
(MOOSE) recommendations (23). Most studies are cross sectional or case-control, which have 
the potential for recall bias and are less reliable in establishing causality. Cross-sectional studies 
are disadvantageous in exploring links between toxic occupational exposures and Parkinson’s 
disease, due to prevalence-incidence or Neyman bias (24). Any toxic occupational exposure that 
would have resulted in death would have been under-represented among those with the disease 
(25), especially in the case of PD which is a longer-lasting and progressive disease. On the other 
hand, there are fewer systematic reviews with meta-analyses on cohort studies demonstrating the 
impact of toxic occupational exposures on the prevalence of PD. In addition, to limited 
systematic reviews and meta-analysis on high quality longitudinal studies, toxic occupational 
exposure in most cross sectional or case-control studies have generally been measured via 
questionnaires or other recall methods, which may introduce bias.  
The objective of this study is to (1) determine the strength of association between overall 
toxic occupational exposures and three types of toxic occupational exposure (metals, 
electromagnetic and pesticides) and the occurrence of PD and (2) understand the relationship 
between toxic occupational exposures and PD by sources of diagnostic information. The focus of 
this study is on longitudinal studies which use robust means of assessing toxic exposures and 
outcome (PD) as these are more advantageous than case-control studies in determining relative 
risk as well as establishing incidence. Our analysis is based on sub-analyses according to three 
categories of toxic occupational exposure and methods of diagnosis.  
This study adds updated information that helps to clarify the nature and strength of the 
relationship between the more common types of toxic occupational exposures and PD and 
summarizes a comparison of the results in one study. One advantage of this study is that it 
demonstrates which subgroups of occupational exposures result in greater risks of PD. This study 
differs from more recent longitudinal systematic reviews on toxic occupational exposures in that 
it focuses on methods of diagnosis of PD and includes more recently published studies. It is 
anticipated that more recent studies would include those of better quality. Such findings can help 
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to inform where interventions would be most effective in reducing risks of exposures leading to 
Parkinson’s disease.  
3.3 Methods – Systematic review and meta-analysis 
The systematic review and meta-analysis was conducted according to the PRISMA 
guidelines, 2009 revision (26), and the Meta-analysis of Observational Studies in Epidemiology 
(MOOSE) recommendations (23). All studies included in the analysis were of high quality based 
on our assessment criteria (Appendix C). 
3.3.1 Search strategy 
Publications were identified by a computerized search on EMBASE, PubMed/Medline, 
Toxnet, LILACS, and Cochrane. These databases were searched because they include 
publications on environmental toxins and toxic occupational exposures and public health or 
general health outcomes. The search was conducted for the period January 1990 to March 2019 
using varying combinations of the following key words: prospective, retrospective, historical, 
cohort study, occupation, occupational, horticulture, pesticide applicators, pesticide(s), 
herbicides, insecticides, fungicides, mining, bauxite, aluminum, manufacturing workers, 
Parkinson, Parkinsonism, and Parkinsonian. Reference lists of the eligible articles and grey 
literature were also searched for additional studies. The review was limited to studies published 
in English in peer-reviewed journals. All titles or abstracts were screened to determine the 
eligibility of the publication for inclusion in the review.  
3.3.2 Inclusion and exclusion criteria  
A publication was evaluated for further review if the following inclusion criteria were 
met: (1) workers were identified as vulnerable to toxic occupational exposure (farmers, 
gardeners, greenhouse workers, pesticide applicators, shipbuilders, utility workers, railway 
employers, nurses exposed to airborne metals etc.); (2) the outcome included Parkinsonian 
disorders or related diseases (cited as Parkinson's disease, Parkinsonism); (3) original data from a 
cohort design was presented; 4) inclusion of a statistical indicator (relative risk, odds ratio, 
hazard ratio) or original data to estimate the relationship between occupational exposure and PD; 
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and 5) controlled for potential confounders by using statistical adjustment in the analysis or 
matching in the study design. Studies were excluded if they were experimental studies, or 
focused only on genetic data or if they were published in languages other than English. Studies 
were excluded if they did not identify Parkinson's disease cases or provide sufficient data to 
determine an estimator of relative risk (RR) and its confidence interval (CI) for PD. Age was not 
an inclusion/exclusion criterion in our study. 
3.3.3 Data collection and quality assessment 
Full-text of all articles for studies that initially met our inclusion criteria were retrieved 
for further examination. Two authors [TC-R and YS] independently determined eligibility of 
articles for inclusion in the review, with consultation and discussion to resolve any dichotomy in 
suitability of articles. Data on the first author's name, publication year, cohort characteristics, age 
at enrollment, sample size, occupational chemical exposure assessment, as well as disease 
definition were extracted independently (3). We compared the results of this exercise and 
obtained consensus before performing the meta-analysis. The Newcastle–Ottawa Scale (NOS) 
criteria was used to characterize study quality (27).  
3.3.4 Statistical analyses 
We grouped toxic occupational exposures according to the different and specific types: 
electromagnetic exposures, metal exposures and pesticides exposures. We also grouped 
occupational exposures according to methods used to assess outcomes: International 
Classification of Diseases (ICD) codes, medical records (self-reported diagnosis of PD or PD 
identified in medical records with no specific ICD code), and neurologists’/nurses’ confirmation 
of PD. Meta-analyses were conducted using rate ratios (RR) for all included prospective studies.  
Summary effect estimates and their corresponding 95% CIs were calculated using the 
DerSimonian and Laird random-effects model which incorporated the amount of variances 
produced by differences between and within studies, and also taking the results of heterogeneity 
test into consideration (28). Statistical heterogeneity between studies was quantified using 
Cochran’s Q test and the I2 statistic. The significance of the Q test was indicated by a 
corresponding p value lower than 0.05. I2 with a value of 0% indicates no observed 
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heterogeneity, with 25% as low, 50% as moderate, and 75% as high heterogeneity (29). 
Sensitivity analysis assessed the influence of lower quality studies on overall estimates by 
recalculating RRs with the exclusion of lower quality studies for each sub-group analysis. 
Publication bias was evaluated by inspection of funnel plots visually and Egger’s test 
statistically (30-31). Comprehensive Meta-Analysis, version 2.2 (Biostat Inc, Englewood, NJ, 
USA) was used to analyze the data. We considered p values that were less than 0.05 statistically 
significant. All statistical tests were two-sided. 
3.4. Results 
3.4.1 Meta-analysis 
3.4.1.1 Selection of articles 
To maximize the number of relevant publications retrieved, the search process included a 
combination of MeSH terms using applicable key words or title search related to “Parkinson’s 
Disease,” and “herbicides,” “pesticides”, “fungicides”, “insecticides”, “heavy metals” 
“electromagnetic fields” (Appendix A). 
 Figure 3-1 outlines the search process. We identified 1058 relevant titles in our initial 
search. This number was reduced to 872 titles following exclusion of duplicates. An additional 
803 articles were discarded after the title/abstract review which resulted in 69 potentially 
relevant full text articles screened. Another 45 articles were removed after failing to meet 
inclusion criteria, resulting in a final list of 24 articles that met the criteria for meta-analysis and 
were included in the study. Figure 3-1 indicates reasons for exclusion from the study during full-
text screening. 
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Figure 3- 1 PRISMA flowchart – Toxic occupational exposures and Parkinson’s disease  
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Twenty-four articles met our inclusion criteria. Data from the selected articles were 
extracted and kept electronically for easy retrieval for additional analysis. The extracted data 
included authors, year of publication, cohort characteristics, sample size, exposure, and outcome 
of interest, assessment of exposure and outcome, and other relevant information (Table 3-1). The 
twenty-four articles that were included in the analysis are fully referenced in Appendix B.  
Table 3-1 provides a detailed summary of the study characteristics of the articles included 
in the review. Sample sizes ranged from 284 to 5,138,648, with a total sample size of 9,570,178 
for all 24 studies included in the analysis. A total of 5,606,328 males and 3,911,099 females and 
52,751 unclassified for sex were included in the study from countries such as the USA including 
Hawaii, Denmark, South Korea, England and Wales, Switzerland, Sweden, France, The 
Netherlands, and Australia.  
A modified NOS assessment scale was utilized in assessment of the quality of the 
included studies. The original scale was modified to separate tools developed for cohort and 
case-control studies after it was tested on systematic reviews. We used the modified scale 
developed for cohort studies in our quality assessment. The quality assessment was based on the 
external and internal validity of the studies. External validity included representativeness of the 
population, cohort representative of the target population and demonstration that outcome of 
interest was not present at start of study. Internal validity included assessment of exposure 
(security of records and validity of information), assessment of outcome (length and adequacy of 
follow up, and acceptable case definition and/or assessment), comparability of study design 
including appropriate control of confounding (Appendix C). 
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Table 3- 1 Summary of study characteristics 
First Author and 
Year 
Cohort Characteristics Age (yrs.) at 
Enrolment 
No. of Subjects 
(male/female) 
Exposures Exposure Assessment PD Diagnosis Quality 
Assessment 
Fryzek et al., 2005 Retrospective cohort; 1977 to 
2002; Danish metal-
manufacturing employees. 
37  27,839/0 Occupation (metals) Self-administered questionnaire 
of occupational histories. 
ICD8, code-342.0 and 
ICD10, code-G20. 
Fair  
Palacios et al., 2014 Prospective cohort of US 
nurses; 1976 with biennial 
questionnaires.  
30-55 0/121,701 Occupation (metals) National Air Toxics 
Assessments on exposures to 
select metals. 
Self-reporting verified 
by medical record. 
Good 
Park et al., 2006 Retrospective cohort; 1970 and 
2002; South Korean 
shipbuilding employees.  
n/a 38,560/0 Occupation (manganese) Airborne manganese 
concentration. 
ICD10, code-G20-G26 
as the primary or 
auxiliary diagnosis 
were used. 
Good  
Tüchsen et al., 2000 Prospective cohort; 1981 to 
1993; Danish agricultural 
workers. 
20-59  90,430/38,505 Occupation (pesticides) Occupational groups (farming, 
horticulture, forestry and related 
fields). 
ICD-8, code-342. Good  
Johansen et al., 2000 Retrospective cohort; 
employees of Danish utility 
companies between 1900 and 
1993 and the Danish National 
Register of Patients 978 to 
1993. 
18-66  24,580/5,781 Occupation 
(electromagnetic) 
Utility workers employment 
records, Danish Supplementary 
Pension Fund and the files of 
the public payroll 
administration of all Danish 
counties. 
ICD-8, code-342.99. Good  
Beard et al., 2003 
 
Retrospective cohort; 1935 to 
1996; field officers, office staff 
or laboratory staff for the Board 
of Tick Control, Australia. 
n/a 1,984/0 Occupation (pesticides) Board of Tick Control records 
indicating chemical usage. 
Insurance and death 
records; mailed 
questionnaire. 
Fair  
Willis et al., 2010 Retrospective cohort; medicare 
part A beneficiaries enrolled 
since 1995, living in the United 
States in the year 2003.  
n/a 2,685,857/ 
2,452,791 
 
 
 
 
 
 
 
  
Metals Toxic Release Inventory facility 
location 
and onsite metal release and 
waste management activities.  
ICD-9, code 332.0, 
332.1 and 333.0  
Good  
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Sorahan and Kheifets, 
2007 
Employees of the former 
Central Electricity Generating 
Board of England and Wales; 
1971-1993. 
n/a 72,954/11,043 Occupation 
(electromagnetic) 
Occupational exposures were 
assessed by the EMF Research 
Section of the National Grid 
Company.  
ICD-8 and ICD-9. Good  
Röösli et al., 2007 Swiss railway employees; 1972 
to 2002. 
n/a 20,141/0 Occupation 
(electromagnetic) 
Electromagnetic measurements 
and modelling.  
ICD-8 and ICD-10. Fair  
Sorahan and 
Mohammed, 2014 
Employees of the former 
Central Electricity Generating 
Board of England and Wales; 
1973-2010.  
n/a 62,825/10,226 Occupation 
(electromagnetic) 
Exposure assessments for power 
stations and transmission 
workers.  
ICD-8, code 342 and 
ICD-10, code-G 20-21, 
and G25.9.  
Fair  
Baldi et al., 2003 Elderly people, aged 65 years or 
older, living at home or in an 
institution in Gironde, 
southwestern France was 
followed from 1987. 
≥ 65  1,122/1,670 Pesticides Detailed occupational histories 
from specific questionnaires. 
Trained neurologist 
confirmation of a 
diagnosis of 
Parkinson’s disease. 
Good  
Feldman et al., 2011 Prospective cohort; Swedish 
men s followed for up to 43 
years. 
44  20,225/0 Occupation (pesticides) A job exposure matrix (JEM) 
based on occupation at baseline. 
National Patient 
Register (NPR) and the 
Cause of Death Register 
(CDR). 
Good  
Pedersen et al., 2017 Employees of private and public 
utility companies in Denmark 
1900-1993.  
16-66  32,006/0 Occupation 
(electromagnetic) 
A job-exposure matrix. ICD-8 and ICD-10. Good  
Brouwers et al., 2014 A sub cohort of the Netherlands 
Cohort Study followed up for 
cause-specific mortality; 1986-
2003. 
55-69  58,279/62,573 Occupation 
(electromagnetic) 
Occupational history 
questionnaire 
ICD-9, code 332.0 and 
ICD-10, code-G20.   
Good  
Engel et al., 2001 A cohort study; men exposed to 
pesticides; 1972-1976. 
69.6 (49-96)  310/0 Occupation (pesticides) Self-administered questionnaire 
on pesticide use. 
Unified Parkinson’s 
disease rating scale 
(UPDRS). 
Fair  
Petrovitch et al., 2002 Prospective cohort; men of 
Japanese ancestry living on the 
island of Oahu, Hawaii; 1965-
1996. 
53.0 (45-68)  7,986/0 Occupation (pesticides) Self-reported years of work on 
plantations and exposure to 
pesticides. 
Hospitalization records 
and verification of 
diagnosis by 
neurologist. 
Fair  
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Kenborg et al., 2012 Retrospective cohort: Danish 
steel production workers; 1964-
1984 
16–66  10,058/1 Occupation (metals) A mailed questionnaire. ICD-8: 342; ICD-10: 
G20, ICD-8: 342.1; 
ICD-10: G21, ICD-10: 
G22 
Fair  
Kenborg et al., 2012 Prospective cohort; Danish 
professional gardeners;1977-
2008. 
≥35  3,124/0 Occupation (pesticides) Danish Union of Gardeners 
membership delineated 
exposure to pesticides. 
ICD-8, code 342 and 
ICD-10 code G20. 
Good  
Wastensson et al., 2006 Prospective cohort; Swedish 
diphenyl-impregnated paper 
production workers; 1954 to 
1970.  
44-55  264/20 Occupation (pesticides) Company files and trade union 
cards that indicated job titles 
and time of employment. 
Neurologist identified 
cases based on signs 
and response to 
levodopa treatment. 
Fair  
Ascherio et al., 2006 Prospective cohort; US farmers; 
enrolled in 1993-1997, and 
followed in 1997-2001. 
male: 63.7 
(41-90); 
female: 62.0 
(40-85) 
86,404/97,786 Pesticides Questionnaire on occupation 
and exposure to selected 
chemicals or dusts. 
Questionnaire; medical 
records  of treating 
neurologists that 
confirmed PD. 
Fair  
Kamel et al., 2006 Prospective cohort; restricted 
use pesticide-applicators; 
enrolled in 1993-1997, and 
followed in 1999-2003.  
n/a 52751 (sex 
undefined) 
Occupation (pesticides) Questionnaires on  pesticide 
exposure. 
Self-reported PD 
diagnosis by a 
physician at enrollment 
and follow-up. 
Good  
Park et al., 2005 Retrospective cohort of 
National Occupational Mortality 
Surveillance System; 1992-
1998 . 
n/a 1,683,783/930,5
63 
Occupation 
(electromagnetic, 
pesticides) 
Job exposure matrix and 
occupational classification by 
proportionate mortality rates. 
ICD:331.0. Good  
Håkansson et al., 2003 Prospective cohort; Swedish 
engineering industry workers; 
1985-1996.  
35  537,692/180,529  Occupation 
(electromagnetic) 
Job exposure matrix and 
occupational classification from 
Nordic version of the 
International Standard for 
Classification of Occupations 
(ISCO).  
ICD-9, code 332.0. Good  
Savitz et al., 1998 A cohort mortality study electric 
utility workers between 1950 
and 1986. 
n/a 139,905/0 Occupation 
(electromagnetic) 
Job histories and occupational 
categories.  
ICD 8, code 342 and 
ICD-9, code 331.0. 
Fair  
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The reviewed articles were categorized according to (1) occupational exposures and (2) 
methods of outcome assessment. Each category had several groups, occupational exposures: (a) 
overall toxic exposures (b) electromagnetic exposures; (c) metal exposures; and (d) pesticide 
exposures and methods of outcome assessment: (a) ICD codes, (b) medical records and (c) 
confirmation by neurologists/nurse. Some articles examined more than one type of toxic 
exposure leading to inclusion in multiple separate analyses. When broken down by types of toxic 
exposures, a total number of 35 studies were analyzed. We report on these studies first looking at 
overall toxic exposures, followed by electromagnetic studies, metal studies, and finally, pesticide 
studies. 
Twenty-four articles [32-55] used longitudinal study designs to examine the relationship 
between toxic occupational exposures and Parkinson’s disease. Most of these studies used the 
ICD codes in varying classifications, medical records or neurologists’ confirmation to ascertain 
PD diagnosis (Table 3-1). Figure 3-2 shows the individual studies, pooled estimates, and funnel 
plots for (a) all toxic occupational exposures and (b) electromagnetic exposures; (c) metal 
exposures; and (d) pesticide exposures. A random effects model was used to calculate the 
summary effect estimates and their corresponding 95% confidence intervals (CIs).  
3.4.1.2 Relationship between toxic occupational exposures and PD 
The pooled RR (Table 3-3) for toxic occupational exposures among study subjects 
diagnosed with PD was 1.15 (95% CI 1.06–1.24, χ2 = 10.75, I2 = 0.00%, p = 0.001) indicating 
that any toxic occupational exposure is a significant risk factor for PD as those with a history of 
exposure were 1.15 times more likely to be diagnosed with PD than those without history of 
toxic exposures. The Egger’s test (p=0.217) and funnel plot in Figure 3-2a indicated that there 
was no evidence of heterogeneity or publication bias for overall toxic occupational exposures.  
3.4.1.2.1 Relationship between occupational electromagnetic exposures and PD 
Nine articles [36, 39-41, 44-45, 53-55] were used to examine the relationship between 
electromagnetic exposures and PD.  PD diagnosis was assessed through ICD codes. Six studies 
reported an association between PD and occupational electromagnetic exposures, while the other 
three studies did not find an association. A random effects model was used. Figure 3-2b shows 
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the individual study and pooled estimates, and funnel plots. The pooled RR (Table 3-3) for PD 
for those who were occupationally exposed to electromagnetic forces as opposed to those who 
were not was 1.03 (95% CI 0.91–1.16, χ2 = 0.22, I2 = 12.55%, p = 0.642). This indicates that 
those working in occupations where they were exposed to electromagnetic fields were 1.03 times 
more likely to develop PD than those who were not exposed to magnetic fields in their 
occupations. 
As demonstrated in Figure 3-2b, the funnel plot shows that all studies were within the 
95% confidence interval domain. There was no evidence of heterogeneity or publication bias 
(Egger’s test, p = 0.418). The influence of study quality on overall estimates was assessed by 
omitting lower quality studies from the analysis. The analysis yielded an electromagnetic 
exposure RR of 1.02 (95% CI 0.85 -1.25), clearly demonstrating that occupational 
electromagnetic exposure was a risk factor for Parkinson’s disease . 
3.4.1.2.2 Relationship between occupational metal exposures and PD 
Fourteen articles [32, 33a-h, 34, 38a-c] were used to examine the relationship between 
metal exposures and PD.  PD diagnosis was assessed through ICD codes and medical records. 
Nine studies reported an association with occupational metal exposures and PD, with one study 
reporting a significant association, while five studies did not report an association. A random 
effects model was used. Figure 3-2c demonstrates the individual study, pooled estimates, and 
funnel plots. The pooled RR for PD (Table 3-3) for those who were occupationally exposed to 
metals as opposed to those who were not was 1.07 (95% CI 0.92–1.24, χ2 = 0.76, I2 = 0.00%, p = 
0.385). This indicates that those occupationally exposed to metals were 1.07 times more likely to 
develop PD than those who were not exposed to magnetic fields in their occupations. 
As demonstrated in Figure 3-2c, the funnel plot shows that all studies were within the 
95% confidence interval domain. There was no evidence of heterogeneity or publication bias 
(Egger’s test, p = 0.329). Sensitivity analysis yielded metal exposure RR of 1.08 (95% CI 0.92 -
1.27), clearly demonstrating that occupational metal exposure was a risk factor for Parkinson’s 
disease. 
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3.4.1.2.3 Relationship between occupational pesticide exposures and PD 
Twelve articles [35, 37, 42-44, 45-48, 50-53] were used to examine the relationship 
between metal exposures and PD.  PD diagnosis was assessed through ICD codes, insurance, 
medical and death records, neurologist or nurse’s confirmation of self-reported diagnosis and one 
mailed questionnaire. Eleven of the twelve studies reported an association between occupational 
pesticide exposure and PD, with half of the associations being significant. A random effects 
model was used. Figure 3-2d shows the individual study and pooled estimates, and funnel plots. 
The pooled RR (Table 3-3) for PD for those who were occupationally exposed to pesticides as 
opposed to those who were not was 1.41 (95% CI 1.20–1.65, χ2 = 16.99, I2 = 26.24%, p = 
0.000). This indicates that those working in occupations where they were exposed to pesticides 
were at significant increased risk or 1.41 times more likely to develop PD than those who were 
not occupationally exposed to pesticides. 
As demonstrated by the funnel plot in Figure 3-2d, all studies were within the 95% 
confidence interval domain. However, there was moderate heterogeneity and publication bias 
(Egger’s test, p = 0.003). Sensitivity analysis yielded pesticide exposure RR of 1.28 (95% CI 
0.99 -1.62), clearly demonstrating that occupational pesticide exposure was a risk factor for 
Parkinson’s disease. 
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Figure 3-2 a Relationship between overall toxic occupational exposures and PD  
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Figure 3-2 b Relationship between occupational electromagnetic exposure and Parkinson’s 
disease 
    
     
 
 35 
 
 
Figure 3-2 c Relationship between occupational metal exposure and Parkinson’s disease  
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Figure 3-2 d Relationship between occupational pesticide exposure and Parkinson’s disease  
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3.4.1.3 Relationship between toxic occupational exposures and PD by diagnostic methods  
When the relationship between toxic occupational exposures and PD was analyzed 
according to methods of diagnosing PD, the pooled RR, 2.17 (95% CI 1.32-3.54, χ2 = 9.49, I2 = 
7.83%, p = 0.002) was highest and significant in those whose diagnosis was confirmed by a 
neurologist or nurse using standardized assessment methods. The lowest pooled RR was 1.06 
(95% CI 0.92-1.21, χ2 = 0.62, I2 = 8.54%, p = 0.002). This represented an insignificant 
association between toxic occupational exposures and PD diagnosis confirmed through medical 
records.  
There was a significant association between toxic occupational exposure and PD 
diagnosis confirmed by ICD codes, RR 1.14 (95% CI 1.03-1.26, χ2 = 6.45, I2 = 8.09%, p = 
0.011) (Figure 3-3 and Table 3-3). The Egger’s test (p=0.676; 0.228; and 0.217) and funnel plots 
in Figure 3-3 indicated that there was no evidence of heterogeneity or publication bias for toxic 
occupational exposures leading to PD diagnosed through ICD codes, medical records, and 
confirmation by neurologist/nurse, respectively. 
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Figure 3-3 a Relationship between overall toxic occupational exposures and PD diagnosed by 
ICD codes 
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Figure 3-3 b Relationship between overall toxic occupational exposures and PD diagnosed by 
medical records 
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Figure 3-3 c Relationship between overall toxic occupational exposures and PD confirmed by 
neurologist or nurse  
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3.4.1.4 Summary of findings  
The major finding of our analyses is that, though all toxic occupational exposures result 
in increased risk of being diagnosed with PD, those individuals working in occupations where 
they are exposed to pesticides are at significant risk and are most likely to be diagnosed with PD 
(Table 3-2). The strongest association between toxic occupational exposure and PD was 
observed in those whose PD diagnosis was confirmed by a neurologist or nurse. 
Table 3- 2 Summary of results of meta-analysis 
Study Group Risk ratios 
(RR) 
95% Confidence interval 
(CI) 
p-value 
Toxic Occupational Exposures    
Overall exposures 
Electromagnetic exposures 
Metal Exposures 
Pesticide exposures 
1.15 
1.03 
1.07 
1.41 
1.06-1.24 
0.91-1.16 
0.92-1.24 
1.20-1.65 
0.001 
0.642 
0.385 
<0.001 
Diagnostic Methods    
ICD Codes 
Medical Records 
Neurologists’/Nurse’s Confirmation 
1.14 
1.06 
2.17 
1.03-1.26 
0.92-1.21 
1.32-3.54 
0.011 
0.431 
0.002 
 
We assessed heterogeneity and publication bias of the subgroups using Cochran’s Q test 
and the I2 statistic (Table 3-3). Pesticide exposures demonstrated low heterogeneity and 
significant risk for publication bias, while electromagnetic exposures, metal exposures and 
overall exposures showed no to low heterogeneity and insignificant risk for publication bias. No 
publication bias or heterogeneity was found among toxic occupational exposures. 
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Table 3- 3 Heterogeneity and publication bias results of subgroup meta-analyzed studies. 
Study Groups Number 
of 
studies 
Heterogeneity Publication Bias 
Q-value df (Q) I2 t value P value (two-tailed) 
Occupational Exposures 
Overall exposures 
Electromagnetic 
exposures 
Metal exposures 
Pesticide exposures 
35 
 
9 
14 
12 
46.08 
 
9.148 
10.519 
14.913 
34.000 
 
8.000 
13.000 
11.000 
26.219 
 
12.548 
0.000 
26.237 
1.261 
 
0.860 
1.016 
3.526 
0.217 
 
0.418 
0.329 
0.003 
Diagnostic methods 
ICD codes 
Medical records 
Confirmation by a 
neurologist/nurse 
19 
12 
 
4 
19.585 
12.027 
 
3.255 
18.000 
11.000 
 
3.000 
8.093 
8.537 
 
7.829 
0.425 
1.284 
 
1.261 
0.676 
0.228 
 
0.217 
3.5 Discussion 
This meta-analysis demonstrated that people in occupations where there were toxic 
exposures had a greater risk of being diagnosed with PD when compared to those who had no 
toxic occupational exposures. Of a total of 35 studies, 26 studies (74.3%) suggested increased 
risk of PD due to toxic occupational exposures. The pooled RR between any type of toxic 
occupational exposure and PD was 1.15 (95% CI 1.06-1.24). For select types of toxic 
occupational exposures, the RRs were: electromagnetic exposure, RR =1.03 (95% CI 0.91-1.16); 
metal exposure RR=1.07 (95% CI 0.92-1.24); and pesticide exposure RR= 1.41 (95% CI 1.06-
1.65). Specific studies that reported an increased risk of PD were published between 2000 and 
2014, generally had larger sample sizes, well-defined exposure and outcome assessments as well 
as longer periods of follow-up.  
 Our results show toxic occupational exposures in general and exposure to 
electromagnetic fields, metals and pesticides as significant risk factors for PD. Several meta-
analyses, using similar rigorous quality assessment criteria for exploring the association between 
various types of occupational exposures on PD diagnosis, support our finding that toxic 
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occupational exposures are associated with an elevated risk of developing Parkinson’s disease (6; 
56; 57).  
This study further confirms the association between toxic occupational exposures found 
in two earlier studies (17 & 58). The pooled RR for metal exposure, 1.07 (95% CI 0.92-1.24) 
reported in this review was greater than the RRs reported in one of the earlier studies (58) which 
showed a negative association between metal exposure and PD, RR 0.98 (95% CI 0.53-1.81) and 
0.85 (95% CI 0.82-0.89). The pooled RR for electromagnetic exposure, 1.03 (95% CI 0.91-1.16) 
in this review was slightly greater than the RRs, 1.02 (95% CI 0.83-1.26) and 1.02 (95% CI 0.90-
1.16), respectively reported in both earlier studies (17 & 58). The pooled RR for pesticide 
exposure, 1.41 (95% CI 1.20-1.65) in this review was lower than those reported in both earlier 
studies (17 & 58), 1.66 (95% CI 1.42-1.94) and 1.67 (95% CI 1.42-1.97), respectively. Despite 
being lower than the RRs for pesticide exposure reported for other studies, the RR for pesticide 
exposure in this study is consistent with the finding in the literature that exposure to pesticide 
results in a significantly higher risk of Parkinson’s disease than any other toxic exposures. 
 Publication bias may have influenced the results for pesticide exposure, partially 
explaining the higher risk estimate. Studies published more recently, i.e. after 2005 showed no 
publication bias (p=0.249) and a slightly lowered risk when compared to studies published 
before 2005 (p=0.003). Though the heterogeneity was negligible, this could be attributable to 
control selection, differences in methods used to assess toxic occupational exposures, variations 
in study design, and length of follow-up (15).  
What this study adds new to the literature is pooled risk estimates of PDs based on common 
types of toxic occupational exposure and diagnostic assessment of outcome. Our meta-analysis 
found that when studies were grouped according to outcome assessment methods, no publication 
bias was indicated and risk estimates were higher for those whose diagnosis was confirmed by a 
neurologist or nurse using standardized assessment methods. This finding may be attributable to 
the fact that disease has progressed significantly at this stage and there is no doubt about an 
accurate PD diagnosis for individuals in this group, indicating a strong association between toxic 
occupational exposures and PD.  
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3.5.1 Strengths and Limitations of the Current Study 
A general limitation of meta-analyses is that risk estimates can only be calculated based 
on data from previously published studies. Such calculations will reproduce any intrinsic 
weaknesses in the study design of those publications (17). In addition, previous publications of 
meta-analyses on Parkinson’s disease have included those studies identified as relevant, 
regardless of their quality. One limitation of this study is that occupational exposures were 
assessed through a variety of methods in published data, with little focus on the dosage of 
exposure. Based on the lack of uniformity of exposure, we selected risk estimates spanning many 
years of exposure to minimize heterogeneity.  Another limitation of our study is that in several of 
the included publications, PD was diagnosed using ICD codes which include both PD and 
secondary parkinsonism (Table 3-1). Parkinsonism is caused by different pathophysiological 
mechanisms than Parkinson’s disease and may be related to different occupational exposures and 
pathogenesis (56). However, this limitation was overcome by stratifying studies according to 
method of diagnosis as part of our meta-analysis, yielding increased risk for PD despite the 
method of diagnosis.  
One strength of our study is that the meta-analysis included studies that were of high 
quality, having met our robust quality assessment criteria. Another strength is that we employed 
multiple methods to find all potential sources of publication bias; we stratified data to account 
for potential confounders and used varied methods of evaluating publication bias such as 
stratification by publication year, funnel plots and the Egger’s test (17). Other strengths of our 
study include the large sample size from different regions of the world; longitudinal study 
designs; adequate periods of follow-up; relative recency of included studies; and the number of 
studies included in the analyses. 
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3.6 Conclusion 
The results of review and meta-analysis in this study provide robust confirmation that overall 
toxic occupational exposures are significantly and strongly associated with the development of 
PD. Occupational pesticide exposure, in particular, showed a greater level of association with PD 
that was confirmed by a neurologist/nurse using standardized methods. This may suggest that the 
risk in the development of PD may be more markedly increased with the duration or frequency 
of exposure to pesticide (19), as opposed to exposure to metals and electromagnetic fields. As 
the findings of this study are consistent with those of previous high quality studies, additional 
studies with similar methodologies may not result in significantly novel findings. Further 
reviews and meta-analyses of longitudinal studies of high quality should focus on prospective 
designs, but with more definitive exposure assessments and PD diagnosis confirmed by a 
neurologist/movement disorder specialist using standardized guidelines. 
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Appendix A: Search Strategy 
The following MeSH terms and free terms related to “Parkinson’s Disease,” and “herbicides,” 
“pesticides”, “fungicides”, “insecticides”, “heavy metals” “electromagnets” were combined to 
retrieve the maximum number of relevant publications: (Idiopathic Parkinson’s Disease OR 
Lewy Body Parkinson Disease OR Lewy Body Parkinson’s Disease OR Primary Parkinsonism 
OR Idiopathic Parkinson Disease OR Parkinson’s Disease OR Parkinson Disease OR Parkinson 
Patients OR Parkinson Patient OR Parkinson’s Patients OR Parkinson’s Patient OR Paralysis 
Agitans) AND ((Herbicides OR Methyl Viologen OR Gramoxone OR Paragreen A OR paraquat 
OR paraquat poisoning OR paraquat poisoned patients OR paraquat poisoned patient OR 
paraquat intoxication OR paraquat concentration OR neurotoxicity of paraquat OR paraquat 
neurotoxicity OR fungicide toxicity OR insecticides OR fungicides OR agricultural chemicals) 
OR (heavy metals OR Actinium OR Americium OR Antimony OR Barium OR Berkelium OR 
Bismuth OR Cadmium OR Californium OR Cesium OR Cesium Isotopes + OR Chromium OR 
Chromium Isotopes + OR Cobalt OR Cobalt Isotopes + OR Copper OR Curium OR Einsteinium 
OR Fermium OR Francium OR Gallium OR Gallium OR Isotopes + OR Germanium OR Gold 
OR Gold Isotopes + OR Hafnium OR Indium OR Iridium OR Iron OR Iron Isotopes + OR 
Lawrencium OR Lead OR Manganese OR Mendelevium OR Mercury OR Mercury Isotopes + 
OR Molybdenum OR Neptunium OR Nickel OR Niobium OR Nobelium OR Osmium OR 
Palladium OR Platinum OR Plutonium OR Protactinium OR Radium OR Rhenium OR Rhodium 
OR Rubidium OR Ruthenium OR Silver OR Strontium OR Strontium Isotopes + OR Tantalum 
OR Technetium OR Thallium OR Thorium OR Tin OR Tungsten OR Uranium OR Vanadium 
OR Zinc OR Zinc Isotopes + OR Zirconium) OR (electromagnetic OR electromagnets OR 
electromagnetism)). 
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 Appendix C: A summary of the Newcastle -Ottawa Scale (NOS) quality assessment for selected studies 
 
Assessment item 
Study 
Fryzek 
(2005) 
Palacios 
(2014) 
Park 
(2006) 
Tüchsen 
(2000) 
Johansen 
(2000) 
Beard 
(2003) 
Willis  
(2010) 
Sorahan 
&Kheifets 
(2014) 
Röösli 
(2007) 
Sorahan 
&Mohammed 
(2014) 
Baldi 
(2003) 
Feldman 
(2011) 
Pedersen 
(2017) 
Brouwers 
(2014) 
Engel 
(2001) 
Petrovitch 
(2002) 
Kenborga 
(2012) 
Kenborgb 
(2012) 
Wastensson 
(2006) 
Ascherio 
(2006) 
Kamel 
(2006) 
Park 
(2005) 
Håkansson 
(2003) 
Savitz 
(1998) 
Selection                         
1. Representativeness of 
the population 
                        
a) truly representative 
of  the average, elderly, 
community-dwelling 
resident 
0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 
b) somewhat 
representative of the 
average, elderly, 
community-dwelling 
resident 
0 0 0 1 0 0 1 0 0 0 1 0 0 1 1 0 0 0 0 0 1 1 1 0 
c) selected group of 
patients, e.g. only 
certain socio-economic 
groups/areas 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
d) no description of the 
derivation of the cohort 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
2. Selection of the non-
intervention cohort 
                        
a) drawn from the same 
community as the 
intervention cohort 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
b) drawn from a 
dif ferent source 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
c) no description of the 
derivation of the non-
intervention cohort 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
3. Ascertainment of 
intervention 
（exposure） 
                        
a) secure record (e.g. 
health care record) 
1 1 0 1 1 1 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 
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b) structured interview 0 0 1 0 0 0 0 1 1 0 1 1 1 1 0 0 0 1 1 0 0 1 0 0 
c) written self -report 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
d) other / no description 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
4. Demonstration that 
outcome of interest was 
not present at start of 
study 
                        
a) yes 0 1 1 1 1 0 1 0 0 0 1 0 1 0 0 1 1 1 0 1 1 0 0 0 
b) no 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Comparability                         
1. Comparability of 
cohorts on the basis of 
the design or analysis 
                        
a) study controls for 
age, sex, marital status 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
b) study controls for 
any additional factors 
(e.g. socio-economic 
status, education) 
0 1 0 0 1 1 1 1 0 1 1 1 1 1 1 1 0 1 0 1 1 1 1 1 
Outcome                         
1. Assessment of 
outcome 
                        
a) independent blind 
assessment 
0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 0 1 0 0 0 0 1 
b) record linkage 1 0 1 1 1 0 1 1 1 1 0 1 1 1 0 0 1 1 0 0 0 1 1 0 
c) self -report 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
d) other / no description 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
  
 
5
5
 
2. Was follow up long 
enough for outcomes to 
occur 
                        
a) yes, if  median 
duration of follow-
up >= 6 month 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
b) no, if  median 
duration of follow-up < 
6 months 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
3. Adequacy of  follow 
up of  cohorts 
                        
a) complete follow up: 
all subjects accounted 
for 
0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 0 0 
b) subjects lost to follow 
up unlikely to introduce 
bias:  number lost <= 
20%,  or description of 
those lost suggesting no 
dif ferent from those 
followed 
1 1 0 0 0 1 0 1 1 0 1 0 0 1 0 0 0 0 0 0 1 0 0 0 
c) follow up rate < 80% 
(select an adequate %) 
and no description of 
those lost 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
d) no statement 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Overall 5 6 6 6 6 5 7 6 5 5 8 6 7 7 5 5 5 6 5 5 6 6 6 5 
Note: Kenborga: Parkinson’s disease among gardeners exposed to pesticides-a Danish cohort study; Kenborgb: Parkinson’s disease and other neurodegenerative disorders among welders: a Danish cohort study. 
For each component of the quality assessment, 1 denotes that the criterion has been met; 0 denotes that the criterion has not been met.
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CHAPTER 4 – TRENDS IN PREVALENCE OF SELF-REPORTS OF ALZHEIMER’S 
DISEASE/DEMENTIA AMONG NON-INSTITUTIONALIZED INDIVIDUALS 45+IN 
CANADA, 1994-2014 
 
A version of this chapter will be submitted for journal publication review. 
 
 
The analysis presented in this paper was conducted at the Saskatchewan Research Data Centre 
(SKY-RDC) which is part of the Canadian Research Data Centre Network (CRDCN). The 
services and activities provided by the Saskatchewan Research Data Centre (SKY-RDC) are 
made possible by the financial or in-kind support of the SSHRC, the CIHR, the CFI, Statistics 
Canada, and the University of Saskatchewan. The views expressed in this paper do not 
necessarily represent the CRDCN’s or that of its partners’. 
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4.1 Abstract 
Background: The risk of developing Alzheimer’s disease/dementia (AD) appears to be modified 
by a combination of demographic, lifestyle, and medical factors. Improved treatments of heart 
disease, hypertension and stroke have resulted in decreased mortality from these diseases and are 
expected to contribute to a decline in prevalence of AD/dementia. While there were 340,000 
people living with dementia in 2011 with a projected doubling by 2031, there are few Canadian 
trend studies on prevalence of AD, the most common of the dementias. This study aims to (1) 
describe the trends in the overall prevalence of self-reported AD/dementia and in men and 
women in different age groups, educational levels and geographic areas in Canada from 1994 to 
2014 and (2) assess what the observed trends mean in the context of the aging Canadian 
population and the health care system.   
Methods: A trend analysis was conducted using data from the cross-sectional National 
Population Health Surveys, 1994/1995-1998/1999 and the Canadian Community Health Survey, 
2001/2001-2014. Trends in age-sex standardized prevalence estimates were calculated and 
assessed over time. 
Results: The overall prevalence of AD/dementia increased from 0.14 in 1994 to 0.80 in 2014 
representing a 0.66% increase over the twenty-year period. The increasing trend in AD/dementia 
prevalence was found across all strata of the population and mostly among men aged 65 or older, 
those with lower levels of educational attainment and those living in Central Canada. 
Conclusions: The overall prevalence of AD/dementia in the community increased over time. We 
conclude that the increase in prevalence is partly attributable to more people living longer in the 
community in Canada due to increased survival rates and early intervention for chronic 
conditions which are risk factors for AD/dementia. The high life expectancy and projected 
growth of the elderly population, and the findings of our study emphasize the importance of 
establishing effective community-based prevention strategies that focus on minimizing risk and 
optimizing protection as well as health system capacity strengthening and preparation for long-
term care including increased demand for neurologists’ services, increased associated disability 
and psychosocial difficulties, rising costs, caregiver burden.  
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4.2 Introduction 
 Alzheimer’s disease (AD) is one of the most common types of dementias and 
neurological conditions. In 2006, there were 26.6 million people impacted globally by AD and 
related dementias (1). By 2050, the global prevalence of dementias including AD is expected to 
quadruple and 1 in 85 people is projected to be living with the disease (2). In Canada, there were 
340,000 people living with dementia in 2011 with a projected doubling by 2031 (3). The 
economic burden on the Canadian health system is tremendous. In 2008, the total economic 
burden of care for dementia was approximately $15 billion. This cost is projected to increase to 
$153 billion by 2038 (4). The number of older persons with dementia living in the community is 
expected to steadily rise, exacerbated by a projected shortage of long-term care beds (5).  
The risk of developing dementia appears to be modified by a combination of 
demographic, lifestyle, and medical factors. Diseases such as hypertension and diabetes 
contribute to cardiovascular and cerebrovascular diseases (2, 6, 7). Individuals with obesity and 
cardiovascular, and cerebrovascular diseases are at higher risk for dementia and AD (8, 9-11).  
Obesity has been linked with changes in the structure of the brain, resulting in cognitive decline, 
dementia and AD (12, 13). 
Notwithstanding these risks, dementia is expected to decrease because there has been a 
significant decline in the incidence of stroke in recent decades. In Canada, improved treatments 
of heart disease, hypertension and stroke have resulted in decreased mortality from these diseases 
(14). One study identified increasing prevalence but decreasing incidence of AD/dementia in 
Saskatchewan (15). There is also evidence to suggest that the prevalence of AD/dementia is 
decreasing in younger cohorts and that these trends are likely to occur across developed countries 
(16, 17). On the other hand, there may be more individuals especially in the older population 
with increased risk of dementia due to advances in medical interventions which contribute to an 
improvement in survival after stroke, or an increased prevalence of underlying vascular disease 
despite not presenting with stroke or its effects (2).  
Formal education and more wealth have been identified as protective for the risk of 
dementia (18). More years of formal education are associated with a reduced risk of dementia 
including AD. Over time, there has been an increase in the level of education among older adults 
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impacting brain development and function, and better health behaviors. The general health 
advantages of having more education and social opportunities may have influenced the 
prevalence of AD/dementia (19, 20).  
A diagnosis of Alzheimer’s disease/dementia means cognitive impairment, dependency, 
caregiver burden, and premature death (21). Despite the depth of impact of AD/dementia on 
individuals and caregivers, Canadian studies focusing specifically on the trends of AD/dementia 
are lacking. Studies on the epidemiology of dementia generally provide estimates of overall 
dementia and are not specific to causes such as AD (22, 23). In addition, some studies have 
shown that AD/dementia is declining in the younger age cohorts and ballooning in the oldest old 
age categories, with prevalence projections focusing on those in the highest age categories, 
otherwise called the oldest old. This may lead to appropriating health care interventions to only a 
select group of people to the neglect of others who also may need to be targeted. Updated 
information on the trends of dementia specifically due to AD is needed in Canada if we are to 
ensure that adequate and appropriate resources are mobilized to deal with the needs of those with 
this condition and their families who are most times severely impacted. Such studies can also 
inform prevention strategies and approaches to management.  
This study provides evidence on the prevalence of Alzheimer’s disease/dementia at the 
population level. Estimates were derived from two sets of national health surveys over a 20-year 
period conducted by Statistics Canada during the period 1994 to 2014: The National Population 
Health Surveys (NPHS) and the Canadian Community Health Surveys (CCHS).  
The objectives of this study are:  
1. To describe the trends in the overall prevalence of self-reported AD/dementia and in men 
and women in different age groups, educational levels and geographic areas in Canada 
from 1994 to 2014. 
2. To assess what the observed trends mean in the context of the aging Canadian population 
and the health care system.  
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4.3 Methods 
4.3.1 Data Sources 
Health surveys are conducted by Statistics Canada each year among randomly chosen 
individuals residing throughout Canada. In this study, we used data from 2 different but similar 
sets of Canadian health surveys.  We examined data from the 10 provinces and where available 
the three territories of Canada: NL, NB, NS, PEI, QC, ON, MB, SK, AB, BC and NU, YT and 
NT. To allow ease of comparison across all twenty years, as well as graphical presentation, and 
maintenance of confidentiality of individual data, the provinces and territories were categorized 
into four regions: Eastern Canada (NL, NB, NS, PEI); Western Canada (MB, SK, AB and BC); 
Central Canada (QC and ON) and Territories (NU, YT and NT). 
Our first source of data from 1994-1999 was the PUMF data from the NPHS which is 
both a cross-sectional as well as a longitudinal study carried out by Statistics Canada (24). The 
first phase of data collection in the NPHS took place in 1994 and served as both a cross sectional 
study and the starting part for a longitudinal study which ended in 2010/2011. The data was 
collected, as far as possible, using face-to-face interviews of a nationally representative cohort of 
17,276 household residents. In the period covering 1994 to 1999, the NPHS survey collected 
cross-sectional data on a representative sample of the Canadian population every two years. 
However, the sample was selected from the 10 provinces only and did not include those living in 
the territories. Therefore, for the period 1994-1999, no data on Alzheimer’s disease/dementia 
prevalence was reported for the territories. 
The second source of data from 2000-2014 was the anonymized Master Files from the 
CCHS which replaced the NPHS and used similar sampling procedures as that survey. Unlike 
the NPHS, this survey included individuals living in the 10 provinces as well as the territories of 
Canada. Originally, CCHS surveys were conducted every 2 years, starting in 2001 (CCHS 1.1). 
Subsequent surveys were conducted in 2003 (CCHS 2.1), in 2005 (CCHS 3.1), and in 2007 
(CCHS 4.1) (25). In those years, large sample sizes of approximately 130,000 respondents were 
interviewed. Significant changes were made to the survey design in 2007 to account for the 
structure of the Canadian population. As a consequence, the sample size was lowered to 
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approximately 65,000, with data now being collected on an ongoing basis with annual releases. 
For surveys conducted after 2007, roughly one-half of the sample was interviewed in person and 
one-half by telephone using computer assisted telephone interviewing (25).  
Both the NPHS and CCHS allow for proxy responses (information provided on behalf of 
others). These type of responses represented less than 10% of the total responses for all years of 
the surveys utilized in this thesis. As well, for the serious condition of Alzheimer’s/dementia, 
there were no differences between estimates generated by proxy and non-proxy responses (26, 
27). A survey weighting factor based on age groups, sex, marital status, educational levels, and 
provincial difference is supplied by Statistics Canada. Population estimates can be calculated 
from this weighting (24, 25). Ethics approval was not required for this study as it involved 
analysis of anonymized secondary survey data which contained no personal identifiers. 
4.3.2 Measures of Alzheimer’s disease/dementia 
In all surveys between 1994 to 2014, the questions on Alzheimer’s disease/dementia was 
similar: “Do you have Alzheimer's disease/other dementia diagnosed by a health professional?” 
Respondents aged 45 years and over with Alzheimer’s disease/dementia were included in this 
analysis. In some instances, variable categories for provinces and territories, and educational 
level were collapsed to preserve confidentiality of data. Alzheimer’s disease/dementia 
prevalence estimates were generated for 1994, 1996, 1998, 2001, 2003, 2005, 2007, 2008, 2009, 
2010, 2011, 2012, 2013 and 2014. 
AD/dementia prevalence was analyzed by age, sex, province of residence and educational 
level. We categorized respondents with AD/dementia according to their highest level of 
education such as “less than secondary”, “secondary graduation”, “some post-secondary”, and 
post-secondary graduation”. We further categorized respondents with AD/dementia into the four 
regions based on their province of residence. We also categorized age of AD/dementia 
respondents into three groups: 45–64; 65–79; and 80+, accounting for differences in sex.  
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4.3.3 Statistical analyses 
The analyses of this study involved estimating frequencies and prevalence of 
AD/dementia by sex, age group, region of residence and educational level for each study 
population from 1994-2014. Data analysis of the CCHS Master Files was conducted under 
confidentiality restrictions of the SKY-RDC at the University of Saskatchewan. Population 
frequencies were estimated using Statistics Canada survey specific sampling weights. This was 
followed by the use of direct standardization to estimate prevalence to account for changes in the 
demographic structure of the population and population-weighted estimates over time. 
Standardization was performed based on the population size and age and sex distributions in 
2001 to facilitate comparison of frequencies over time (28)). We treated AD/dementia values 
recorded as, “not stated”, “don’t know”, “not applicable” and “refusal” as missing values and 
excluded them from subsequent analyses. 
AD/dementia prevalence was generated to reflect the age–sex groupings for each year 
included in the study. Stratified analyses were performed according to age groups, sex, region of 
residence and educational level to identify trends in Alzheimer’s/dementia prevalence over time. 
Study results are presented in both tabular and graphic forms. All analysis was conducted using 
STATA 14 (StataCorp LP, College, TX, USA).  
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4.4 Results 
4.4.1 Trends in overall Alzheimer’s disease/dementia prevalence in Canada  
The overall prevalence of Alzheimer’s disease/dementia increased from 1994 to 2014. 
There was a steady increase in prevalence from 1994 to 2001, with a significant rise in 
prevalence in 2003, followed by a decline in 2005 and 2010 and again in 2014 (Figure 4.1). Over 
the period 1994 to 2014, the highest prevalence rates were recorded in 2011 to 2013 with the 
highest standardized prevalence (1.06%) reported in 2013 (Table 4.1, Figure 4.1). In 2014, 
Alzheimer’s/dementia prevalence at endpoint (0.80%) remained the same as it was at midpoint in 
2007 (Table 4.1). Table 4.1 indicates that prevalence of Alzheimer’s/dementia increased between 
the period 1994 to 2013, from 0.14% to 1.06%. This represented an increase of 0.92 percentage 
points.  
 
Table 4- 1 Adjusted prevalence of Alzheimer’s disease/dementia from 1994 to 2014 
Survey Year Alzheimer’s/dementia Prevalence (%) 
1994 0.14 
1996 0.55 
1998 0.54 
2001 0.57 
2003 0.81 
2005 0.71 
20071 0.80 
2008 0.85 
2009 0.82 
2010 0.78 
2011 0.90 
2012 0.94 
2013 1.06 
2014 0.80 
 1 Midpoint  
According to Figure 4.1, the Alzheimer’s/dementia prevalence dipped below expected 
estimates in 1996 to 2008 and surpassed the expected estimates between 1999 to 2001. The 
period 2001-2012 saw an expected incline in overall AD/dementia prevalence (Figure 4.1). 
Though there was a plateau in overall AD/dementia prevalence between 1998 and 2001, overall 
prevalence of AD/dementia among Canadians 45-64 years of age was at an all-time high, with 
the steady increase in trend for that period reflected in the 65-79 and 80+ age categories (Figure 
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4-1, Table 4-2). Males accounted for the highest increase in overall AD/dementia prevalence 
between 1994-2014 (Figure 4-1, Table 4-2). 
Figure 4- 1 The overall prevalence of Alzheimer’s disease/dementia in the Canadian health 
survey population, over the period 1994-2014 
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Table 4- 2 Trends in the prevalence of Alzheimer’s disease/dementia diagnosed by a physician in Canadian health surveys over the 
period 1994-2014 
 Adjusted percentage of persons with Alzheimer’s disease/dementia and percentage change in trends 1994-2014 
 
1994 1996 1998 2001 2003 2005 2007 2008 2009 2010 2011 2012 2013 2014 
Change 
(% pts2) 
Men and Women 
45-64 yrs. 0.04 0.20 0.19 0.10 0.14 0.15 0.10 0.22 0.14 0.16 0.25 0.29 0.22 0.17 
 
0.13 
65-79 yrs. 0.31 0.76 0.68 0.87 1.21 1.11 1.21 1.41 1.18 0.85 1.30 0.99 1.28 1.14 
 
0.83 
80+ yrs. 0.34 2.62 2.82 3.29 4.77 3.82 5.05 4.01 5.08 5.43 4.69 5.91 7.02 4.63 
 
4.29 
Total std1 0.14 0.55 0.54 0.57 0.81 0.71 0.80 0.85 0.82 0.78 0.90 0.94 1.06 0.80 
 
0.66 
Women 
45-64 yrs. 0.03 0.26 0.25 0.06 0.12 0.17 0.12 0.21 0.10 0.12 0.11 0.34 0.25 0.11 
 
0.08 
65-79 yrs. 0.45 0.60 0.68 0.76 0.99 1.07 1.13 0.26 0.88 0.59 1.17 0.91 1.27 0.91 
 
0.46 
80+ yrs. 0.40 2.73 3.09 3.33 3.83 3.36 3.89 3.67 4.28 5.12 4.34 5.27 6.67 4.59 
 
4.19 
Total std1 0.18 0.61 0.66 0.59 0.74 0.74 0.79 0.86 0.75 0.76 0.84 1.01 1.20 0.79 0.61 
Men 
45-64 yrs. 0.04 0.14 0.13 0.14 0.16 0.14 0.08 0.23 0.17 0.20 0.39 0.24 0.18 0.24 
 
0.20 
65-79 yrs. 0.16 0.95 0.67 1.01 1.47 1.16 1.30 1.60 1.52 1.17 1.46 1.09 1.30 1.43 
 
1.27 
80+ yrs. 0.22 2.41 2.29 3.33 6.62 4.71 7.33 4.67 6.65 6.04 5.37 7.16 7.70 4.70 
 
4.48 
Total Std1 0.08 0.48 0.40 0.54 0.88 0.67 0.82 0.84 0.90 0.79 0.96 0.86 0.91 0.81 
 
0.73 
1 Total prevalence for men and women, women, and men, standardized according to the age distribution in 2001 
2Percentage points
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4.4.2 Sex differences in the prevalence of Alzheimer’s disease/dementia 
Figure 4-2 demonstrates that for the period 1994 to 2001, Alzheimer’s disease/dementia 
prevalence was higher in females than in males, followed by a lower AD/dementia prevalence in 
females than males in 2003, 2007, 2009-2011 and 2014. Female AD/dementia prevalence 
surpassed male AD/dementia prevalence in 2005, 2008, and 2013. We observed that for the 
entire period, 1994-2014, males experienced a higher increase in AD/dementia prevalence than 
females, though in latter years (2012 and 2013) the increase is much greater for females than for 
males. For both sexes, AD/dementia prevalence was slightly less than expected between 1996 
and 1998 and higher than expected for males between 1998 and 2001. Female prevalence of 
AD/dementia was slightly lower than expected between 2012 and 2014 (Figure 4-2). 
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Figure 4- 2 The prevalence of Alzheimer’s disease/dementia in Canada, by sex over the period 
1994-2014. 
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4.4.3 Age differences in the prevalence of Alzheimer’s disease/dementia 
According to Figure 4-3, AD/dementia prevalence is highest among men and women in 
the 80+ age category followed by the 65-79 age category and lowest in the 45-64 age category.  
Increases in AD/dementia prevalence was most evident among men and women in the 80+ age 
category when compared to the younger age categories, 45-64 and 65-79. While there is a 
noticeable increase in AD/dementia prevalence among men and women in the 80+ age category 
for the period, 1994-2014, the trends in AD/dementia prevalence are holding steady for men and 
women 45-64 and 65-79 age categories (Figure 4-3). 
The highest prevalence for each of the sexes was recorded in 2013 and in the 80+ age 
category.  Additionally, in the 65-79 age category, there was a marked increase in AD/dementia 
prevalence in males (1.27%) compared to females (0.46%), with increases in prevalence from 
1994-2014 being higher in males among all age categories (Table 4-2). As shown in Figure 4-3, 
there was a decline in AD/dementia prevalence in 2005 which was attributable to the decline of 
AD/dementia in all age categories of men in that year. While there was a marked decline in 
AD/dementia prevalence among women in the 65-79 age category in 2008, there was a converse 
incline in AD/dementia prevalence among females in the 45-64 age category with a small 
decrease in the prevalence of AD/dementia among women in the 80+ age category for that same 
year. 
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Figure 4- 3 The prevalence of Alzheimer’s disease/dementia among age groups in Canada, 
1994–2014. 
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4.4.4 Geographic differences in the prevalence of Alzheimer’s disease/dementia 
 We did not observe a significant geographic difference in prevalence of AD/dementia. 
Figure 4-4 shows that AD/dementia prevalence across all ten province and territories increased 
over time and the derived estimates are a good predictor of the expected prevalence for 
AD/dementia. On average, there was a 0.44% increase in prevalence across the country over the 
period 1994-2014 with no change in prevalence for the territories over time and Eastern, Central 
and Western Canada reporting significant above average increases in prevalence of 0.71% and 
0.60% respectively overtime. After 1994, the lowest recorded prevalence among the regions of 
residence in Canada was recorded in as 0.46% in Central Canada. 
There was a sharp increase in prevalence from 0.15% in Eastern Canada to 0.86% in 
2005 and 1.20 % in 2007 followed by a sharp decrease to 0.68% in 2008 and a levelled increase 
from that point to 2012 when there was a marked increase (1.04%) in AD/dementia prevalence, 
followed by a decline resulting in a prevalence of 0.60% in 2014. This reflected a 0.45% increase 
in AD/dementia prevalence in Eastern Canada from 1994 to 2014.  
Central Canada recorded a 0.71% increase in prevalence overtime, from 0.14% in 1994 to 
0.85% in 2004, reflecting the highest increase in prevalence among the regions of residence in 
Canada. Central Canada also recorded the steadiest increases in prevalence between 2005 to 
2013, reflecting marked inclines in 2008 and 2011 and a sharp decline in 2014. 
Western Canada reflected the second highest overall increases in prevalence from 0.11% 
in 1994 to 0.74% in 2014, accounting for a 0.60% overall increase in prevalence for that region. 
The highest prevalence recorded in Western Canada was 1.10% in 2013.  There were other sharp 
inclines in 1996, 2003, and 2008. Apart from 1994, the lowest prevalence recorded in Western 
Canada was 0.59% in 2001. 
The trend in AD/dementia prevalence observed in the territories is similar in undulation 
to that observed in Eastern Canada. The territories had the highest prevalence of AD/dementia 
due to the fact that the number of people living in that region of Canada is small compared to 
that of other provinces and regions in Canada. Figure 4-5 demonstrates that though there was a 
marked increase from 0.54% in 2005 to 4.68% in 2009, this was followed by a steady decline to 
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0.54% in 2013 resulting in no real change in the overall prevalence of AD/dementia in the 
territories over the period for which data was available. 
Figure 4- 4 The prevalence of Alzheimer’s disease/dementia according to region of residence in 
Canada, 1994–2014. 
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4.4.5 Educational differences in the prevalence of Alzheimer’s disease/dementia 
We observed educational differences in AD/dementia prevalence overtime. The average 
all time increase in prevalence by education was 0.74%. Figure 4-5 and Table 4-3 show that the 
highest number of prevalence estimates >1.00% was recorded in those with the lowest level of 
education, i.e., those who had less than secondary education. Those in the category of less than 
secondary education also recorded an above average increase in prevalence of 1.22% over the 
period 1994-2014. Though overall increase in prevalence was higher in those who had completed 
secondary education (0.70%) than in those with some post-secondary education (0.52%), yearly 
prevalence increases were higher among those who had some post-secondary education in 1994, 
1996, 2001, 2008, 2009, 2010 and 2012.  
There was little difference between the overall increase in prevalence between those who 
graduated post-secondary and those who had some post-secondary education (Table 4-3). 
Additionally, those who reported post-secondary graduation reported a steadier increase in 
prevalence compared to those who reported some post-secondary education, who had more 
significant shifts in prevalence increases overtime, suggesting a more protective relationship 
between the completion of higher levels of education and AD/dementia than mere exposure to 
higher education. 
Figure 4- 5 The prevalence of Alzheimer’s disease/dementia according to level of education in 
Canada, 1994 –2014. 
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 Table 4- 3 Trends in the prevalence of Alzheimer’s disease/dementia by level of education in Canadian health surveys 
over the period 1994-2014 
  
Adjusted percentage of persons with Alzheimer’s disease/dementia and percentage change in trends 1994-2014 
 
Levels of Education 
1994 1996 1998 2001 2003 2005 2007 2008 2009 2010 2011 2012 2013 2014 
Change 
(% pts2) 
Less than secondary 0.18 0.67 0.57 0.66 1.00 1.05 0.91 0.94 0.96 0.79 1.61 1.39 1.19 
 
1.40 
 
1.22 
Secondary grad 0.11 0.39 0.63 0.47 0.76 0.54 1.15 0.73 0.99 0.79 0.78 0.82 0.79 
 
0.81 
 
0.70 
Some post secondary 0.12 0.50 0.60 0.64 0.74 0.52 0.51 0.77 1.03 1.02 0.91 1.60 0.66 
 
0.64 
 
0.52 
Post-secondary grad 0.10 0.43 0.39 0.57 0.62 0.58 0.62 0.83 0.60 0.70 0.64 0.73 1.12 
 
0.63 
 
0.53 
Total std1 0.14 0.55 0.54 0.57 0.81 0.71 0.80 0.85 0.82 0.78 0.90 0.94 1.06 0.80 
 
0.66 
 
1 Total prevalence for men and women, women, and men, standardized according to the age distribution in 2001 
2 Percentage points 
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4.5 Discussion 
 There are not many studies that have examined national trends in AD/dementia 
prevalence in Canada over time. Other studies focused on a single province, a subgroup in the 
population, all dementias or predicted overall change in prevalence from a single point in time to 
some future time period decades later (3, 15, 29-31). While these studies examined prevalence, 
they did not look at annual trends over time or by strata within the population.  More studies 
focusing on trends in AD/dementia and dementia prevalence were conducted internationally (2, 
32-37). It is difficult to compare the results of such studies due to the variation of dementias 
included, characteristics of the study populations including strata, age and sex standardization 
and differences in the period or country studied (38,39). 
Notwithstanding, previous studies reported findings similar to our study. We found that 
the prevalence of AD/dementia recorded an overall 0.66-point increase between 1994-2014, and 
a 5.12-point increase in individuals 65+ years of age, in that same period. One study which also 
focused on age and sex standardized prevalence estimates for AD/dementia using Ontario data, 
found that the prevalence over time was increased by 18.2 % in individuals 66+ years of age 
(29). This finding was corroborated by Sekita et al. (2010), who studied prevalence of 
AD/dementia in Japan (32). The increase in prevalence of AD/dementia over time may be 
attributable to the continued increase in size of the older population, growing awareness of the 
disease (2) and earlier diagnosis of cognitive deficits (40). Our study showed small increases in 
prevalence year over year, but bigger increases overtime, signifying smaller increases in 
incidence of AD/dementia, and declining mortality, resulting in more people living longer with 
the disease (41). Improved mortality among those at risk for AD/dementia may be caused by 
improved survival rates for strokes and cardiovascular diseases, largely due to more public health 
promotion activities targeted to nutrition and other life style factors, leading to earlier 
identification and treatment of lifestyle related diseases (e.g. diabetes and hypertension), greater 
control of serum lipid levels, and decreases in cigarette smoking (2, 42). 
We observed that the prevalence of AD/dementia increased with age in both men and 
women across all years, but increased significantly after age 80. This is consistent with the 
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findings from previous studies (32, 39, 43), which is in keeping with the expectation that, over 
time, there will be a greater number of the elderly living in the community and with 
AD/dementia (5, 40). While the increase in prevalence of AD/dementia was consistent with age 
in both males and females, our study found that over time, there was a greater increase in 
prevalence among men than women. This finding is contradictory to some studies which report 
that AD/dementia prevalence is greater among women than men (32, 43-45). On the other hand, 
the more recent Canadian study with similar methodology (29) supported our finding that 
although prevalence rates were highest among women, the increase in the rate over time was 
greater among men. This higher prevalence in men may be an artifact of survey methodology 
which excluded those living in institutions (24, 25). Women are more likely to live in long term 
care facilities after a confirmation of AD/dementia as opposed to men who spend more time 
living in their communities after AD/dementia diagnosis (47). On the other hand, 
neurodegeneration and development of clinical symptoms significantly contributing to mortality 
are more severe and progress faster in women than in men (48-51), resulting in less women with 
AD/dementia living in the community.  
We did not observe a significant geographic difference in the prevalence of AD/dementia 
throughout the years. However, there was variation in the level of AD/dementia prevalence 
increase across all provinces, over time. Few trend studies highlighting geographic differences 
have been published in Canada. It is therefore difficult to make adequate comparisons. 
Venketasubramanian, Sahadevan, Kua, Chen, & Ng, 2011, suggest that if regional variations in 
Alzheimer’s disease/dementia exist, they exist for reasons other than lack of standardization of 
rates or differences in diagnostic protocols across the country (52). Lack of geographic variations 
in AD/dementia prevalence year over year may be because of population homogeneity in the 
risks and duration of AD/dementia across the country as well as similarities in preventive 
approaches and cultural factors influencing the etiology and expected course of AD/dementia. 
On the other hand, the variations in geographic prevalence increases over time, might be 
explained by differences in genetic, environmental risk and protective factors that may exist 
across provinces (53, 54).  
Our study found that prevalence increases were less among those who had attained higher 
levels of education and increased in those with lower levels of education. This is consistent with 
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data in the literature that indicates that low educational assessment is a risk factor for 
AD/dementia while high educational attainment is protective (18, 55-57). One of the rare 
analyses of Alzheimer’s disease/dementia trends by education, found similar trends in 
AD/dementia. This study indicated that those with less than secondary education had greater 
increases in AD/dementia than secondary graduates who in turn had greater increases in 
AD/dementia than post-secondary graduates (58). Our study found a slightly higher prevalence 
of AD/dementia among those who completed post-secondary education compared to those with 
some post-secondary education. This finding could be explained by the protective association 
between higher education levels and longer life expectancy found in another study (59). In that 
study, Hubbard, et al., explain that individuals with higher education tend to live longer in 
general and with AD/dementia; which is consistent with the slightly higher prevalence of 
AD/dementia observed in those with post-secondary graduation compared to those with some 
post-secondary exposure. Those with higher levels of education and wealth are more likely to 
intentionally seek information and improve health behaviors, leading to reduction in risk factors 
for AD/dementia related to lifestyle factors such as cigarette smoking, nutrition and physical 
activity (60-62). On the other hand, those in the older age categories may have lower levels of 
education associated with cognitive decline attendant with AD/dementia (63), accounting for 
higher increases in prevalence of AD/dementia among the 80+ year groups in our study. This 
higher prevalence of AD/dementia among individuals 80+ indicate that as persons live longer 
with AD/dementia, there may be an increased need for long-term care, whether in the community 
or in facilities, when disease progresses beyond the ability of caregivers (usually spouses of 
similar age) to provide the relevant care required by AD/dementia patients.  
4.5.1 Strengths and limitations of the study 
 Strengths of this study include consistent definition of AD/dementia cases across years, 
the use of nationally representative surveys of the Canadian population over a twenty-year time 
span with relatively high participation rates. Another strength is that our study supports findings 
of similar studies in other jurisdictions. This study impacts the dearth of trend studies on 
Canadian data by updating information to AD/dementia prevalence within several strata of the 
Canadian population, and is a good source of information for the development of targeted public 
health and community-based approaches to AD/dementia. 
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 A major limitation of our study is that the surveys used did not include respondents living 
in institutions including health care facilities and nursing homes. In addition, data was lacking 
for the territories for most years. It is possible that this study may have resulted in an over- or 
under-estimation of AD/dementia prevalence, due to underdiagnoses of AD/dementia in the 
community and variation in participants in the surveys over the years as well as the fact that 
those diagnosed with AD/dementia are more likely to be living in institutions. 
4.6 Conclusion 
The prevalence of AD/dementia has increased steadily over the past 20 years in the 
general population of middle aged and older Canadians. The increasing trend seemed to be 
observed across all strata of the population (age, sex, education and region of residence) and 
mostly among men aged 65 or older, those with lower levels of educational attainment, and those 
living in Central Canada, despite a lack of consistent pattern. Future projections of prevalence of 
AD/dementia in the Canadian population should include data on individuals living in institutions. 
Focus should also be given to the cultural and behavioral drivers of the etiology of the disease, 
reflective of the diversity of the Canadian population. 
Given, the high life expectancy and projected growth of the elderly population, our study 
underlines the importance of establishing effective community-based prevention strategies for 
AD/dementia. It also underscores the need for health system capacity strengthening and 
preparation for increasing challenges associated with long-term care of AD/dementia including 
rising costs, caregiver burden and increased demand for neurologists’ services. Additionally, 
public health prevention strategies that focus on minimizing risk and optimizing protection are 
needed to mitigate against the steady increases in prevalence of AD/dementia in the community. 
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CHAPTER 5 – UNMET HEALTH CARE NEEDS: FACTORS PREDICTING   
SATISFACTION WITH HEALTH CARE SERVICES AMONG COMMUNITY-DWELLING 
CANADIANS LIVING WITH NEUROLOGICAL CONDITIONS IN ONTARIO USING 
DATA FROM CANADIAN COMMUNITY HEALTH SURVEY-ANNUAL COMPONENT, 
2010 
 
A version of this chapter will be submitted for journal publication review. 
 
 
 
 
 
 
 
The analysis presented in this paper was conducted at the Saskatchewan Research Data Centre 
(SKY-RDC) which is part of the Canadian Research Data Centre Network (CRDCN). The 
services and activities provided by the Saskatchewan Research Data Centre (SKY-RDC) are 
made possible by the financial or in-kind support of the SSHRC, the CIHR, the CFI, Statistics 
Canada, and the University of Saskatchewan. The views expressed in this paper do not 
necessarily represent the CRDCN’s or that of its partners’. 
 
 
 
 
 
 
 
 
 
 
 
 84 
 
 
5.1 Abstract 
Background: Neurological conditions can lead to long term challenges with functional 
impairments and limitations to activity. Not surprisingly, people with neurological conditions 
report unmet health care needs and experience barriers to care. Earlier studies indicate that unmet 
health care needs are associated with decreased patient satisfaction with health care services and 
lowered health-related quality of life. There are few studies that examine patient satisfaction with 
health care services among Canadians with neurological conditions as a whole. The goals of this 
study were to (1) explore the factors predicting patient satisfaction with general health care 
services, hospital and physician services among Canadians with neurological conditions and (2) 
contrast patient satisfaction between physician care and hospital care among Canadians with 
neurological conditions. 
Methods: The Canadian Community Health Survey - Annual Component, 2010 (CCHS - 2010) 
was used, in this study, to conduct secondary analyses on a subset of the data, containing a total 
number of 8848 respondents with neurological conditions, of whom 2902 received health care 
services, 1222 received hospital services and 2211 received physician services within twelve 
months leading up to data collection (January-December, 2010). Multivariate logistic regression 
was used to estimate odds ratios and their corresponding confidence intervals for the relationship 
between unmet health care needs and other predictors of satisfaction, and patient satisfaction 
with health care services. 
Results: Excellent quality care predicts higher odds of patient satisfaction with general health 
care services, 237.60 (95% CI 70.43-801.52), hospital services, 166.99 (95% CI 67.91-410.64), 
physician services, 176.45 (95% CI 63.89-487.30). In contrast, self-perceived unmet health care 
needs negatively predicts patient satisfaction across all health care services: general services, 
OR=0.59 (95% CI 0.37-0.93), hospital services, OR=0.41 (95% CI 0.21-0.77), and physician 
services, OR=0.29 (0.13-0.69). Other negative predictors of patient satisfaction include some 
post-secondary education, OR= 0.36 (95% CI 0.18-0.72), general health services, and OR=0.26 
(95% CI 0.09-0.80), physician services; secondary [OR=0.32 (95% CI 0.13-0.76)] and post-
secondary graduation [OR= 0.28 (0.11-0.67)], physician services, and being an ER patient most 
recently, OR=0.39 (95% CI 0.20-0.77), hospital services. 
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Conclusions: We conclude that self-perceived unmet health care needs (attributable to 
availability and quality of care) as a single variable, is a common significant negative predictor 
of neurological patient satisfaction across health care services. This emphasizes the importance 
of ensuring coordinated efforts to provide relevant and accessible care of the highest quality for 
Canadians with neurological conditions. 
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5.2 Introduction 
 Neurological conditions such as Alzheimer’s disease (AD)/dementia, Parkinson’s disease 
(PD), amyotrophic lateral sclerosis (ALS), migraine headaches, multiple sclerosis (MS), 
epilepsy, cerebral palsy, Huntington's disease, stroke effects, Tourette’s syndrome, dystonia, 
muscular dystrophy, spina bifida, brain and spinal cord injuries, brain and spinal cord tumors, 
and hydrocephalus, were the focus of a Statistics Canada survey in 2010 (1). Neurological 
conditions, especially those that grow increasingly debilitating with age, for e.g. PD and 
AD/dementia, lead to long term challenges with functional impairments and limitations to 
activity (2, 3). People with neurological conditions not surprisingly report unmet health care 
needs (4, 5) and experience barriers to care including lack of resources (time and money), lack of 
services and no local specialists (2, 6, 7).  
Self-reported unmet health care need is a commonly used measure of access to 
care/health care utilization (8-10). Health care utilization is impacted by four factors: availability, 
acceptability, accessibility, and personal choice not related to the health system (11-13). 
Perceived unmet health care needs may be categorized according to these health care utilization 
factors as follows: availability – waiting time too long, care not available when requested, care 
not available in area; acceptability – dislike doctor/afraid, language problems, didn’t know where 
to go; accessibility –cost and transportation; or personal choice – too busy, didn’t get around to 
it/didn’t bother, felt it would be inadequate, decided not to seek care, and personal/family 
responsibilities (7, 10).  
 Anderson’s health behavior model describes health care utilization as a function 
of three factors: predisposing, enabling and need. Predisposing factors exist before presentation 
with a health condition and are socio-demographic characteristics and may be socio-cultural in 
nature; enabling factors represent the means or logistics for accessing health services; and need 
factors are the effectual cause of health service use and is a reflection of the perceived health 
status of the health care user (14, 15). The outcome measure for this study, patient satisfaction, is 
widely accepted as an assessment of overall healthcare quality (16, 17). In the same vein, patient 
satisfaction has been found to be positively associated with health related quality of life (an 
individual’s or a group’s perceived physical and mental health over time). (18). Some studies 
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indicate that unmet health care needs result in decreased patient satisfaction with health care 
services (19-21) and thus lowered health care quality and poorer quality of life (22-24).  
An understanding of unmet health care needs and patient satisfaction with health services 
among older Canadians with neurological conditions is crucial in the ongoing evaluation and 
resulting continuous quality improvement of healthcare services for this vulnerable population 
(14). Such knowledge will contribute to the Canadian health system’s preparation of and 
strengthening of services to adequately provide for and meet the needs of the constantly 
increasing aging population. This study examines the impact of unmet health care needs on 
satisfaction with health care services in Canada among those with neurological conditions from 
the CCHS-2010. We incorporate life satisfaction as a predisposing factor in predicting patients’ 
satisfaction with health care system. Life satisfaction presents an overarching view of an 
individual’s satisfaction and would therefore influence one’s satisfaction with the health system. 
The research model for this study utilizes Andersen’s health behavior model follows in figure 5-
1 below: 
Figure 5- 1 Research model of health care utilization in current study based on Andersen’s health 
behavior model 
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The objectives of this study are:  
1. To explore the factors predicting patient satisfaction with general health care 
services, hospital and physician services among Canadians with neurological conditions. 
2. To contrast patient satisfaction between physician care and hospital care among 
Canadians with neurological conditions.  
5.3 Methods 
5.3.1 Data Sources 
Data were extracted from the Canadian Community Health Survey - Annual Component, 
2010 (CCHS - 2010). CCHS-2010 is a cross-sectional survey that collects population-wide 
information pertaining to health status, health care utilization and health determinants of 
Canadians (25). The CCHS data is collected from persons aged 12 and over living in private 
households in the 117 health regions covering all provinces and territories. Persons living on 
lands designated as Indian Reserves or by the Crown, those dwelling in institutions, or in certain 
remote regions as well as full-time members of the Canadian Forces are excluded from this 
survey (25). The survey was conducted between January and December, 2010 using computer 
assisted interviewing (CAI). Approximately half the interviews were conducted in person using 
computer assisted personal interviewing (CAPI) and the other half were conducted over the 
phone using computer assisted telephone interviewing (CATI) (25). The overall person-level 
response rate for the survey was 88.6% and the combined response rate was 71.5% at the Canada 
level (26). 
In addition to the common content answered by all respondents, the CCHS survey 
contains optional content selected at the Health Region level. The optional content despite being 
harmonized across the province, may vary annually and is unique to each region or province 
(26). The CCHS-2010 was used because the data contained one-year unique common content on 
health care utilization: unmet health care needs (UCN) and neurological conditions (NEU) and 
the optional content on patient satisfaction (27), all of interest in this study. Respondents with 
neurological conditions who received health care services and completed the optional module on 
patient satisfaction as well as the unique common content on unmet health care needs resided in 
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the province of Ontario. The population of 10,819,146 in Ontario in 2010 represented a little 
over one-third of the Canadian population in that year. The view of those respondents should 
provide good insight as to what is the concerns of Canadians with neurological conditions. 
Therefore, for this particular study, a subset of the data, containing a total of 8848 respondents, 
living in the province of Ontario with neurological conditions was used. From that number 2902 
who received health care services, 1222 who received hospital services and 2211 who received 
physician services within twelve months leading up to data collection were selected. These 
individuals also completed the modules on unmet needs and patient satisfaction were included in 
the analysis for this study.  
Respondents in age categories 12-44 years were grouped to protect anonymity, due to the 
small sample size of the study population, and the fact that there were very few people in the 
youngest age categories reporting neurological conditions and unmet needs. Proxy responses 
were not utilized for individuals age 12 and above and especially for more serious chronic 
conditions.  Figure 5-2 below demonstrates the restriction criteria used to obtain the subsample 
from the CCHS-2010. 
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Figure 5- 2 Restriction criteria employed to obtain the sub-sample of CCHS-2010 in this study 
 
                           Original CCHS-2010 Population n = 62,909 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Excluded from the analysis  
Original CCHS-2010 Population n = 62,909 
 
Individuals without 
neurological conditions 
n=54061* 
Eligible participants for inclusion (has a neurological condition)  
n =8848 
Individuals with neurological 
conditions who did not receive 
health care services n=5946* 
Final sample with 
neurological conditions 
receiving physician 
health care services  
n =2211 
Final sample with 
neurological conditions 
receiving hospital health 
care services  
n =1222 
Eligible sample with neurological conditions receiving general health care services  
n =2902 
Individuals who did not receive 
hospital health care services 
n=1680* 
Individuals who did not receive 
physician health care services 
n=691* 
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5.3.2 Measures 
5.3.2.1 Assessment of neurological conditions (subpopulation) and patient satisfaction 
(outcome of interest) in CCHS-2010 
 Neurological conditions in the CCHS-2010 sample was derived from a response of yes to 
having a neurological condition. Neurological conditions included in this module were 
AD/dementia, PD, MS, epilepsy, cerebral palsy, ALS, Huntington's disease, stroke effects, 
Tourette’s syndrome, dystonia, muscular dystrophy, spina bifida, brain injuries, SCI, brain and 
spinal cord tumors, hydrocephalus, and migraine headaches. Respondents were included in this 
study if they responded yes to having a neurological condition. 
For this study, the outcome of interest, patient satisfaction, was defined according to 
satisfaction with general health care services, hospital services and physician services. The 
following questions were answered by respondents for each type of care received: 
“Overall, how satisfied were you with the way health care services were provided?”  
“How satisfied were you with the way hospital services were provided?”  
“How satisfied were you with the way physician care was provided?”  
Responses for the levels of satisfaction with the various types of health care services were 
ordinal in nature and coded by categories: 1 = very satisfied, 2 = somewhat satisfied, 3 = neither 
satisfied nor dissatisfied, 4 = somewhat dissatisfied, and 5 = very dissatisfied. For each of the 
patient satisfaction variable (general health care, hospital and physician), categories 1 and 2 were 
collapsed and recoded as “satisfied” = 1, while categories 3-5 were collapsed and recoded as 
“dissatisfied” = 0. 
5.3.2.2 Predictors/covariates 
 We examine the relationship between self-perceived unmet health care needs and patient 
satisfaction. A self-perceived unmet care need (main predictor variable) was identified in the 
CCHS-2010 by the question, “During the past 12 months, was there ever a time when you felt 
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that you needed health care but you didn’t receive it?” Responses were coded, “yes” = 1 and 
“no” = 0. For this variable, reasons for indicating unmet care needs included, unavailability of 
care – waiting time too long, care not available when requested, care not available in area, doctor 
didn’t think care was necessary; unacceptability of care – dislike doctor/afraid, language 
problems, didn’t know where to go; inaccessibility –cost; or personal choice – too busy, didn’t 
get around to it/didn’t bother, felt it would be inadequate, decided not to seek care, and 
personal/family responsibilities. 
Other sociodemographic predictors and covariates that were contained within our 
analyses were:  
Age (< 45, 45-64, 65-79, 80+ years),   
Sex (“male” = 0 vs “female” =1),  
Marital status (“married”, “common-law”, “widowed/divorced/separated”, “single/never 
married”),  
Level of education (“less than secondary”, secondary graduation”, “some post-secondary 
education”, “post-secondary graduation”),  
Total personal income from all sources (less than 20,000, 20,000-39,999, 40,000-69,999, 
70,000 or more), and  
Satisfaction with life in general (“dissatisfied”, “very satisfied”, “satisfied”, “neither 
satisfied nor dissatisfied”), 
Rating of availability of provincial health care: general health care (“poor”, “fair”, 
“good”, “excellent”); hospital services (“poor”, “fair”, “good”, “excellent”); and 
physician services (“poor”, “fair”, “very good”),  
Rating of quality of care received: general health care (“poor”, “fair”, “good”, 
“excellent”); hospital services (“poor”, “good”, “excellent”); and physician services 
(“poor”, “good”, “excellent”),  
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Type of patient at most recent visit (“admitted overnight”, “outpatient”, “ER patient”), 
Type of physician seen at most recent visit (“family doctor” = 0 vs “specialist” =1). 
 Variables that included categories indicated as “do not know”, “refusal” and “not stated” 
were recoded category as (“.”) and treated as missing values. These variables were of interest 
due to their relation to health related quality of life; i.e. self-perceived physical and mental health 
over time. Education, income, gender, influence health status and therefore satisfaction with 
care. General life satisfaction is a global measure of one’s perceived satisfaction as a whole and 
provides overarching context in which health satisfaction may be a part. The availability and 
quality of care received also influences satisfaction with health care services. 
5.3.3 Statistical Analyses 
Data was analyzed using STATA version 14.0. Bootstrapping, which is a statistical 
technique that allows estimation of the sampling distribution of data would normally be applied to 
data collected by random sampling methods. However, due to the small sample size of the study 
population, sampling weights only were applied in order to account for survey design. Descriptive 
statistics were tabulated for the main exposure variable, outcome variable, and covariates as well 
as the socio-demographic factors (age, gender, marital status, education, and personal income) of 
respondents who reported having a neurological condition during the data collection period. To 
account for missing data identified among all variables, prevent loss of information and selection 
bias, multiple imputation was conducted using the chained equations technique in STATA. All 
missing values were retrieved and included in the model building process.  
Univariate logistic regression models were utilized to examine the association between 
self-perceived unmet care needs, other predictors/covariates and satisfaction with health care 
services (general health care, hospital and physician). The unadjusted odds ratios and 95% 
confidence intervals (CI) and p-values were reported. Predictors/covariates with unconditional p-
values ≤0.2 (5) were retained for use in the multivariate model building phase of analysis.  
In the multivariate model building process, variables with p-values >0.05 were individually 
eliminated in sequence of descending p-values, using a manual backward elimination strategy. 
Variables with significant p-values ≤0.05 were retained in the final model. All variables of interest 
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which were manually eliminated due to insignificant p-values were checked for confounding and 
retained when they altered the coefficients for the exposure of interest by >20%. Any variable with 
an initial significant p-value at unconditional analysis that was eliminated by backward elimination 
was assessed for interaction with exposure of interest (self-perceived unmet health care needs). 
All variables were included in the final model. The overall significance of this logistic regression 
model was checked by performing a likelihood ratio test.  
5.4 Results 
5.4.1 Characteristics of the study population – individuals with neurological conditions  
Analysis for this study was limited to the final subsamples of 2902, 1222, and 2211 individuals 
with neurological conditions who received general health care services, hospital services and 
physician services respectively within the 2010 survey year. Table 5-1 below demonstrates the 
demographic characteristics of the study population for all three study samples. Total number of 
weighted cases vary due to missing values. 
Table 5- 1 Sociodemographic characteristics of CCHS-2010 samples 
Characteristics 
 
General Health Care 
Services 
Hospital Services Physician Services 
n(%) n(%) n(%) 
Age categories, years    
≤44 years  3,507 (40.2) 1,242 (35.6) 2,553 (39.6) 
45 to 64  2,725 (31.3) 1,103 (31.6) 2,086 (32.3) 
65 to 79  1,636 (18.8) 758 (21.7) 1,125 (17.4) 
80 and above 844 (9.7) 389 (11.1) 687 (10.7) 
Sex    
Male 2,804 (32.2) 1,091 (31.2) 1,925 (29.8) 
Female 5,908 (67.8) 2,401 (68.8) 4,526 (70.2) 
MARITAL STATUS    
single 2,583 (29.7) 954 (27.4) 1,843 (28.6) 
married 3,515 (40.4) 1,349 (38.7) 2,583 (40.1) 
common-law 413 (4.7) 193 (5.5) 301 (4.7) 
wid/sep/div 2,193 (25.2) 992 (28.4) 1,717 (26.6) 
EDUCATION    
<secondary 2,517 (29.0) 1,033 (29.7) 1,774 (27.6) 
secondary grad 1,569 (18.1) 543 (15.6) 1,116 (17.4) 
other post sec 666 (7.7) 326 (9.4) 485 (7.6) 
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post-sec grad 3,916 (45.2) 1,577 (45.3) 3,046 (47.4) 
INCOME    
<=19,999 3,541 (43.1) 1,468 (44.6) 2,634 (43.3) 
20,000-39,999 2,376 (29.0) 1,037 (31.5) 1,828 (30.1) 
40,000-69,999 1,548 (18.9) 536 (16.3) 1,074 (17.7) 
70,000->100,000 735 (9.0) 252 (7.6) 544 (8.9) 
In all subsamples, the majority of the respondents were females (57.8%), (68.8%) and (70.2%) 
respectively. Most of the respondents were 44 years of age or below (40.2%), (35.6%) and 
(39.6%). Many of the respondents had postsecondary graduation (45.2%), (45.3%) and 47.4%), 
respectively. Most respondents in all samples were married, (40.4%), (38.7%) and (40.1%) 
respectively. Most respondents earned $19,999 or less annually (43.1%), (44.6%) and (43.3%). 
Under 20% of the respondents in each sample reported unmet health care needs. Table 5-2 below 
describes the variables associated with health care services received by the respondents.  
Table 5- 2 Description of variables associated with utilization of health care services: general, 
hospital and physician. 
Variables General Health Care 
Services 
Hospital Services Physician Services 
Unmet Health Care Needs 
 
  
No  7,329 (84.2) 2,797 (80.2) 5,249 (81.4) 
Yes 1,375 (15.8) 691 (19.8) 1,197 (18.6) 
General Life Satisfaction 
 
  
dissatisfied 590 (6.8) 279 (8.0) 434 (6.7) 
very satisfied 2,787 (32.2) 1,012 (29.2) 2,007 (31.3) 
satisfied 4,396 (50.7) 1,822 (52.5) 3,342 (52.1) 
neither satisfied nor 
dissatisfied 
895 (10.3) 359 (10.3) 633 (9.9) 
Rating of availability of  
Provincial care 
 
  
poor 1,218 (14.0) 537 (15.5) 845 (13.2) 
fair 2,182 (25.2) 923 (26.6) 1,647 (25.6) 
good 3,884 (44.8) 1,381 (39.7)  
3,928 (61.2)1 
excellent 1,392 (16.0) 633 (18.2)  
Quality of Care Received 
 
  
poor 299 (3.4) 595 (17.0) 694 (10.8) 
fair 1,072 (12.3)  
1,293 (37.1)2 
 
2,233 (34.6)2 good 3,993 (45.9) 
excellent 3,336 (38.3) 1,599 (45.9) 3,517 (54.6) 
Patient Satisfaction    
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dissatisfied 1,396 (16.1) 660 (18.9) 568 (8.8) 
satisfied 7,299 (83.9) 2,827 (81.1) 5,875 (91.2) 
Most recent patient    
Outpatient - 1,363 (39.0) - 
Admitted Overnight - 817 (23.40) - 
ER Patient - 1,312 (37.6) - 
Physician Type    
Family Doctor - - 5,303 (82.3) 
Specialist - - 1,144 (17.7) 
1 good and excellent categories collapsed to very good  2 fair and good categories collapsed to good 
Most respondents were satisfied with life in general (50.7% -52.5 %) and with health services in 
general (83.9%), hospital (81.1%) and physician services (91.2%). Majority of respondents 
(45.9%) felt they received good health care in general and excellent hospital (45.9%) and 
physician care (54.6%). Most respondents who received hospital services were outpatients (39%) 
while majority of physician services were had from a family doctor (82.3%) (Table 5-2). 
5.4.2 Characteristics associated with patient satisfaction with general health care, hospital, 
and physician services among individuals with neurological conditions (univariate analysis) 
 Based on the results of the univariate analysis shown in Table 5-3, all variables (age, sex, 
marital status, education, income, unmet health care needs, general life satisfaction, availability 
of health care, and quality of care received), excepting sex were significant predictors of patient 
satisfaction with general health care services. The odds of patient satisfaction with general health 
care services increased with age [1.77 (p=0.004), 2.18 (p=0.004), 3.97 (p<0.001)], demonstrating 
a significant positive association with patient satisfaction with health care services in general, 
while there was an insignificant negative association with common law unions (OR = 0.71, 
p=0.297). There was a strong protective association with being married and being satisfied with 
health care services in general (OR= 1.63, p=0.022), while the odds of being satisfied with 
general health care services among all categories of education was negative [0.58, (p = 0.053), 
0.40, (p = 0.004), and 0.76 (p = 0.163)], with the most highly educated being least likely to be 
satisfied with health services in general. There was no significant association between varied 
levels of income and patient satisfaction with general health care services, while unmet health 
care needs demonstrated a strong negative association with patient satisfaction (Table 5-3). The 
greater the availability of provincial health care services, the better the quality of care received 
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and the higher the level of satisfaction with life in general, was the greater the satisfaction with 
general health care services (Table 5-3).  
Age, self-perceived unmet health care needs, availability of health care, and quality of 
care received and patient type at most recent hospital visit significantly predicted patient 
satisfaction with hospital services. The odds of patient satisfaction with hospital services was 
highest among the youngest old (45-64 years), demonstrating the only significant protective 
association among the age categories (2.55, p = 0.001), while those with self-perceived unmet 
health care needs were significantly less likely to be satisfied with hospital services (OR = 0.35, 
p<0.001) than those who health care needs were perceived to be met. The odds of patient 
satisfaction with hospital services significantly increased with the perceived availability of 
provincial health care (fair =3.22, p = 0.001; good = 3.27, p<0.001; and excellent = 18.27, 
p<0.001). The same is true for the association between quality of hospital care received and 
patient satisfaction (fair = OR, 24.34, p<0.001 and very good = OR, 179.11, p<0.001), while 
being admitted overnight (OR = 0.88, p = 0.778) and visiting the ER (OR = 0.17, p<0.001) were 
negatively associated with patient satisfaction with hospital services, with being an ER patient 
demonstrating a strong association with patient dissatisfaction (Table 5-3).   
Unmet health care needs, general life satisfaction, availability of health care, and quality 
of care received were significant predictors of patient satisfaction with physician services. When 
compared with those without self-perceived unmet health care needs, those with self-perceived 
unmet health care needs were significantly less likely (OR = 0.18, p<0.001) to be satisfied with 
physician services, while satisfaction with physician services increased with increasing levels of 
satisfaction with life in general (neither satisfied nor dissatisfied = OR, 2.10, p = 0.150; satisfied 
= OR, 2.21, p = 0.041; and very satisfied = OR, 5.73, p = <0.001). The odds of patient 
satisfaction with physician services significantly increased with the quality of care provided 
(good = 19.61, p<0.001 and excellent = 167.97, p<0.001) and decreased when health care 
services were provided by a specialist (0.63, p = 0.352) compared to a family doctor, though this 
association was not significant. 
In summary, quality of care received, and availability of care were protective predictors 
of patient satisfaction with health care services in general, hospital services and physician 
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services, while self-perceived unmet health care needs was a negative predictor of satisfaction 
which each type of health care service identified above.
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Table 5- 3 Univariate analysis of predictors of patient satisfaction with general health care, hospital, and physician services from CCHS Annual Component 2010 
Variables General Health Care Services Hospital Services Physician Services 
OR, 95% CI p-Value OR, 95% CI p-Value OR, 95% CI p-Value 
Age categories, years  <0.001  0.009  0.140 
≤44 years  Reference  Reference  Reference  
45 to 64  1.77 (1.20-2.62) 0.004 2.55 (1.46-4.46) 0.001 1.36 (0.63-2.96) 0.423 
65 to 79  2.18 (1.29-3.70 0.004 1.74 (0.88-3.47) 0.114 2.01 (0.93-4.33) 0.077 
80 and above 3.97 (1.87-8.45) <0.001 2.02 (0.81- (5.08) 0.133 1.99 (0.90-4.37) 0.087 
Sex  0.633  0.424  0.094 
Male Reference  Reference  Reference  
Female 1.10 (0.74-1.65) 0.663 1.25 (0.72-2.17) 0.424 0.60 (0.33-1.09) 0.094 
Marital Status  0.015  0.104  0.709 
single Reference  Reference  Reference  
married 1.63 (1.07-2.48) 0.022 1.72 (0.96-3.10) 0.068 0.91 (0.47-1.75) 0.775 
common-law 0.71 (0.38-1.35) 0.297 0.88 (0.35-2.19) 0.781 0.70 (0.33-1.51) 0.366 
widowed/separated/divorced 1.53 (0.98-2.37) 0.061  1.85  (0.99-3.45) 0.054 1.10 (0.61-2.00) 0.612 
Education  0.021  0.926  0.085 
<secondary Reference  Reference  Reference  
secondary graduate 0.58 (0.33-1.01) 0.053 1.24 (0.55-2.79) 0.610 0.49 (0.23-1.04) 0.064 
other post-secondary 0.40 (0.21-0.75) 0.004 1.07 (0.43-2.68) 0.889 0.39 (0.17-0.91) 0.030 
post-secondary graduate 0.76 (0.51-1.12) 0.163 0.97 (0.52-1.83) 0.929 0.59 (0.32-1.11) 0.919 
Income  0.146  0.291  0.570 
≤ 19,999 Reference  Reference  Reference  
20,000-39,999 0.90 (0.57-1.43) 0.660 1.12 (0.60-2.10) 0.718 1.16 (0.61-2.20) 0.646 
40,000-69,999 1.59 (1.01-2.53) 0.047 1.46 (0.71-2.99) 0.303 0.95 (0.37-2.48) 0.923 
≥ 70,000 1.28 (0.62-2.62) 0.501 0.55 (0.23-1.30) 0.170 1.94 (0.76-4.97) 0.165 
Unmet Care  <0.001  <0.001  <0.001 
No  Reference  Reference  Reference  
Yes 0.18 (0.12-0.27) <0.001 0.35 (0.20-0.61) <0.001 0.18 (0.10-0.32) <0.001 
General Life Satisfaction  <0.001  0.433  <0.001 
dissatisfied Reference  Reference  Reference  
very satisfied 4.62 (2.41-8.83) <0.001 1.11 (0.44-2.82) 0.819 5.73 (2.61-12.58) <0.001 
satisfied 2.90 (1.72-4.89) <0.001 0.72 (0.34-1.49) 0.372 2.21 (1.03-4.73) 0.041 
neither sat nor dissatisfied 1.75 (0.84-3.67) 0.137 0.59 (0.23-1.47) 0.253 2.10 (0.76-5.77)0. 0.150 
Availability of provincial care  <0.001  <0.001  <0.001 
poor Reference  Reference  Reference  
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fair 2.82 (1.69-4.73) <0.001 3.22 (1.66-6.23) 0.001 1.98 (1.06-3.74) 0.033 
good 9.18 (5.42-15.53) <0.001 3.27 (1.69-6.34) <0.001  
4.29 (1.95-9.63) 
 
<0.001 excellent 27.07 (11.00-66.66) <0.001 18.27 (7.08-47.16) <0.001 
Quality of care received  <0.001  <0.001  <0.001 
poor Reference  Reference  Reference  
fair 9.55 (2.96-30.80) <0.001 24.34 (12.20-48.57) <0.001  
19.61(8.09-47.56) 
 
<0.001 good 77.98 (25.61-237.43) <0.001 
excellent 642.64 (193.27-2136.79) <0.001 179.11 (76.28-420.58) <0.001 167.97 (71.07-396.94)  <0.001 
Most recent patient    <0.001   
Outpatient   Reference    
Admitted Overnight   0.88 (0.35-2.18) 0.778   
ER Patient   0.17 (0.09-0.30) <0.001   
Physician type      0.352 
Family Doctor     Reference  
Specialist     0.63 (0.24-1.66) 0.352 
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5.4.3 Characteristics associated with patient satisfaction with general health care, hospital, 
and physician services among individuals with neurological conditions (multivariate 
analysis) 
Insignificant variables (p=>0.2) were excluded in the initial multivariate logistic 
regression model building. However, after checking for confounding, all variables which were 
originally removed during the initial model building processes were included in the final models 
after checking for confounding because they altered the coefficients for the exposure of interest 
by >20%. Table 5-4 demonstrates the results of the final multivariate logistic regression models 
for patient satisfaction with adjusted predictor and/or covariate variables. Our study generated 
odds ratio estimates to examine the association between sociodemographic factors and 
experiences with health care and patient satisfaction with health care services in general, hospital 
services and physician services among individuals with neurological conditions. 
We found self-perceived unmet health care needs to be a strong negative predictor for 
patient satisfaction across all health care services. For those with self-perceived unmet needs, the 
greatest dissatisfaction was most likely found with physician services (OR = 0.29, p = 0.005), 
followed by hospital services (OR = 0.41, p = 0.006) and then general health care services (OR = 
0.59, p = 0.024), when compared to those without unmet health care needs. Conversely, quality 
of care received and availability of care were significantly strong protective predictors of patient 
satisfaction across all health care services. When compared to those who received poor quality 
care, the odds of patient satisfaction (general health care services, 237.60, p<0.001; hospital 
services,166.99, p<0.001; and physician services, 176.4, p<0.001) were highest across all 
services among those who received excellent quality care; with those receiving general health 
services most likely to be satisfied in all categories of quality care: fair (OR = 6.15, p = 0.002), 
good (OR = 36.37, p <0.001) and excellent (OR = 237.60, p<0.001) (Table 5-4). Regarding the 
association between availability of care and patient satisfaction, the odds of patient satisfaction 
across all health services were higher with increasing availability of care. When compared to 
poor availability of care, the odds of patient satisfaction were highest among those who reported 
excellent availability care across all health care services in general (4.45, p<0.001) and hospital 
services (6.30, p<0.001), with those receiving hospital services most likely to be satisfied across 
all categories of care availability: fair (OR = 2.77, p = 0.011), good (OR = 3.90, p<0.001) and 
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excellent (OR = 6.30, p<0.001). On the other hand, those who reported very good availability of 
physician care were less likely to be satisfied (OR = 1.10, p = 0.833) than those who reported fair 
availability of physician care (OR = 1.25, p = 0.592), though both categories of availability were 
more likely to be satisfied with physician than poor availability of physician care. This 
association between physician care and patient satisfaction was not significant. 
When compared to those 44 years of age or lower, there was decreased odds of patient 
satisfaction with hospital and physician services, respectively, among those with neurological 
conditions in the 65-79 (0.39, p = 0.092; 0.75, p = 0.585) and 80+ (0.48, p = 0.334; 0.73, p = 
0.593) age categories, while those in the 45-64 age category were more likely to be satisfied with 
hospital (OR = 2.02, p = 0.120) and physician services (OR =1.14, p = 0.747). In contrast to age 
playing a negative role in patient satisfaction with hospital and physician services for the older 
age categories, age was associated with an increased likelihood of being satisfied with health 
care services in general, with those 80+ most likely (OR = 2.57, p =0.059) to be satisfied with 
those services, compared to those 44 years of age or lower. Women were more likely to be 
satisfied with general health care services and hospital services and less likely to be satisfied 
with physician services, compared to men. Marital status was a positive predictor for satisfaction 
with health care services in general. In comparison to being single, those who were widowed, 
separated or divorced were most likely (OR = 1.48, p=0.254) to be satisfied followed by those 
who were married (OR = 1.39, p = 0.264), then those who were in common-law unions (OR = 
1.31, p = 0.427). 
Education was a negative predictor of patient satisfaction among those who received 
general health services with higher levels of education being more dissatisfied with care, 
[(secondary graduate, OR = 0.62, p = 0.126); (other post-secondary, OR = 0.36, p = 0.004); and 
post-secondary graduate, OR = 0.54, p = 0.050)] and those who received physician services 
[(secondary graduate, OR = 0.32, p = 0.010); (other post-secondary, OR = 0.26, p = 0.019); and 
post-secondary graduate, OR = 0.28, p = 0.005)], while there were contrasting directions of 
association between the categories education [(secondary graduate, OR = 2.00, p = 0.177); (other 
post-secondary, OR = 2.81, p = 0.065); and post-secondary graduate, OR = 0.98, p = 0.967)] and 
patient satisfaction with hospital services. Other post-secondary education was associated with 
the lowest significant odds of patient satisfaction among those receiving general health services 
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and physician services while it was associated with an increased insignificant odds of patient 
satisfaction with hospital services. In addition, post-secondary graduates provided reduced odds 
of being satisfied with hospital services compared to those with less than secondary education 
and registered least likely chance of patient satisfaction with hospital services in the education 
category. Income on the other hand demonstrated no significant association with patient 
satisfaction across all health care services (Table 5-4). 
Physician type seen and most recent type of patient during last health care services were 
also predictors of patient satisfaction with physician and hospital services respectively. 
Respondents who received specialist care were 47% less likely (OR = 0.47, p = 0.106) to be 
satisfied with physician services than those who saw a family doctor when they last received 
health care services. Patients who were admitted overnight were more likely (OR = 1.20, p = 
0.660) to be satisfied with hospital services than inpatients, while ER patients were significantly 
less likely (OR = 0.39, p = 0.007) to be satisfied with hospital services than both inpatients and 
overnight patients. 
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Table 5- 4 Multivariate analysis of predictors of patient satisfaction with general health care, hospital, and physician services from CCHS Annual Component 2010 
Variables General Health Care Services Hospital Services Physician Services 
OR, 95% CI p-Value OR, 95% CI p-Value OR, 95% CI p-Value 
Age categories, years       
≤44 years  Reference  Reference  Reference  
45 to 64  1.80 (0.98-3.32-) 0.059 2.02 (0.83-4.91) 0.120 1.14 (0.51-2.57) 0.747 
65 to 79  1.24 (0.59-2.59 0.576 0.39 (0.13-1.17) 0.092 0.75 (0.27-2.08) 0.585 
80 and above 2.57 (0.97-6.86) 0.059 0.48 (0.11-2.13) 0.334 0.73 (0.23-2.29) 0.593 
Sex       
Male Reference  Reference  Reference  
Female 1.32 (0.80-2.17) 0.276 1.12 (0.53-2.37) 0.764 0.62 (0.32-1.19) 0.152 
Marital Status       
single Reference  Reference  Reference  
married 1.39 (0.78-2.50) 0.264 0.55 (0.19-1.61) 0.278 0.62 (0.31-1.21) 0.160 
common-law 1.31 (0.67-2.58) 0.427 0.69 (0.23-2.10) 0.514 1.21 (0.42-3.53) 0.727 
widowed/separated/divorced 1.48 (0.76-2.89) 0.254  0.68 (2.01-2.27) 0.524 1.06 (0.41-2.71) 0.603 
Education       
<secondary Reference  Reference  Reference  
secondary graduate 0.62 (0.38-1.14) 0.126 2.00 (0.73-5.47) 0.177 0.32 (0.13-0.76) 0.010 
other post-secondary 0.36 (0.18-0.72) 0.004 2.81 (0.94-8.40) 0.065 0.26 (0.09-0.80) 0.019 
post-secondary graduate 0.54 (0.29-1.00) 0.050 0.98 (0.42-2.28) 0.967 0.28 (0.11-0.67) 0.005 
Income       
≤ 19,999 Reference  Reference  Reference  
20,000-39,999 0.73 (0.41-1.30) 0.281 1.49 (0.58-3.80) 0.404 1.57 (0.69-3.54) 0.278 
40,000-69,999 1.54 (0.75-3.17) 0.242 1.04 (0.36-3.00) 0.939 1.06 (0.33-3.46) 0.917 
≥ 70,000 0.90 (0.39-2.12) 0.817 0.33 (0.11-0.97) 0.045 1.17 (0.38-3.63) 0.783 
Unmet Care       
No  Reference  Reference  Reference  
Yes  0.59 (0.37-0.93) 0.024 0.41 (0.21-0.77) 0.006 0.29 (0.13-0.69) 0.005 
General Life Satisfaction       
dissatisfied Reference  Reference  Reference  
very satisfied 2.15 (1.03-4.49) 0.041 1.56 (0.45-5.41) 0.481 2.53 (0.88-7.26) 0.084 
satisfied 1.80 (0.92-3.53) 0.085 0.77 (0.25-2.33) 0.642 1.24 (0.46-3.37) 0.668 
neither sat nor dissatisfied 1.29 (0.60-2.76) 0.510 0.46 (0.13-1.69) 0.244 1.60 (0.57-4.52) 0.372 
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Availability of provincial care 
poor Reference  Reference  Reference  
fair 1.72 (1.03-2.87) 0.039 2.77 (1.27-6.05)   0.011 1.25 (0.54-2.93) 0.592  
good 3.18 (1.78-5.68) <0.001 3.90 (1.92-7.92) <0.001  
1.10 (0.44-2.75) 
 
0.833 excellent 4.45 (1.76-11.25) <0.001 6.30 (2.35-16.86) <0.001 
Quality of care received       
poor Reference  Reference  Reference  
fair 6.15 (2.00-18.94) 0.002     
good 36.37 (12.09-109.44) <0.001 35.61 (18.71-67.78) <0.001 26.78 (13.36-53.69) <0.001 
excellent 237.60 (70.43-801.52) <0.001 166.99 (67.91-410.64) <0.001 176.45 (63.89-487.30) <0.001 
Most recent patient       
Outpatient   Reference    
Admitted Overnight   1.20 (0.53-2.72) 0.660   
ER Patient   0.39 (0.20-0.77) 0.007   
Physician type       
Family Doctor     Reference  
Specialist     0.47 (0.18-1.18) 0.106 
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In summary, significant positive predictors of patient satisfaction with health care 
services in general are quality and availability of provincial and received care, and being very 
satisfied with life in general. Significant positive predictors of patient satisfaction with hospital 
services are quality and availability of provincial and received care, while the positive predictor 
of patient satisfaction with physician services is quality of care received. Quality of care is 
therefore, strongly and positively associated with patient satisfaction across all health services. In 
contrast, the common significant negative predictor of patient satisfaction across all health care 
services is self-perceived unmet health care needs. Other significant negative predictors of 
patient satisfaction include other post-secondary education (general health services and physician 
services), secondary and post-secondary graduation (physician services), and being an ER patient 
most recently (hospital services) (Figure 5-3). 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
1
0
7
 
Figure 5- 3 Summary of significant associations between health care services and patient satisfaction among individuals with 
neurological conditions 
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5.5 Discussion 
The major findings of our study can be summarized by Anderson’s health behavior 
model predicting health care utilization. This model fittingly demonstrates the relationship 
among predisposing (age, gender, and general life satisfaction), enabling (marital status, income, 
education, availability of health care and quality of care) and need factors (neurological patients’ 
use of general health care services, hospital and physician services) and patient satisfaction. One 
enabling factor, quality of received care, demonstrated a strong positive association with patient 
satisfaction with all health care services received in this study, while another enabling factor, 
availability of provincial care, was positively associated with patient satisfaction with general 
health care and hospital services. One predisposing factor, general life satisfaction, was 
positively associated with patient satisfaction with general health care services. On the other 
hand, a disabling factor, self-perceived unmet health care needs commonly reduced the odds of 
patient satisfaction with the need factors, health care services in general, physician and hospital 
services. Education was deemed a disabling factor, with all levels negatively associated with 
patient satisfaction with physician care and other post-secondary education negatively associated 
with general health care services. The need factor, receiving services at the ER at the last 
encounter with the health system, was negatively associated with patient satisfaction with 
hospital services.  
Of particular interest is the relationship between patient satisfaction and the predisposing 
factor of health care utilization, General Life Satisfaction (GLS) which represents quality of life 
in several studies (28-31). Our finding that GLS was positively associated with patient 
satisfaction with general health care services is consistent with that of other studies which 
reported quality of life, including satisfaction in life domains as positively associated with patient 
satisfaction (32-34). While GLS impacting health related quality of life may be positively 
associated with patient satisfaction with general health care services, significant decreases in 
health related quality of life among people living with long term neurological conditions have 
been reported in other studies (35-41). This suggests that increased levels of GLS positively 
associated with greater odds of patient satisfaction among patients with neurological conditions 
in our study may be impacted by increased health-related quality of life related to enabling 
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factors, availability and the more common predictor of patient satisfaction among all health 
services, quality of care. 
Our study found that while availability and quality of care were positive predictors of 
patient satisfaction across all health services, availability of care was not significantly associated 
with patient satisfaction with physician services. Availability and quality of care are important 
predictors of health related quality of life as satisfied patients are more likely to comply with 
treatment, demonstrate positive health behaviours and register improved health outcomes (42-
44). Consistent with our study, one other study found that quality of care was associated with 
high levels of patient satisfaction among neurological patients (45). The quality of care in that 
study referred to the early connection between patients and neurologists and education and 
advice on living with neurological conditions (45). In another similar study of patients with 
neurological conditions, patient satisfaction with coordination of safe, compassionate, and 
multiple health care services for those with mobility challenges was high (46), supporting our 
finding that when health care services are available, the odds of neurological patient satisfaction 
are increased.  
The association of unmet health care needs, patient satisfaction with health care services 
and health related quality of life have been supported in chronic disease patients, oral health, 
cardiac, and cancer patients (22, 47-54). As patient satisfaction is positively associated with 
health related quality of life (18, 55-57), it may be deduced from this study that self-perceived 
unmet health care needs has some association with health-related quality of life among those 
with neurological conditions, though the direction of that association cannot be predicted from 
this study. One particular study which examined the relationship between unmet health care 
needs and health-related quality of life among patients with multimorbidity (58), found that the 
presence of unmet health care needs was associated with lowered health-related quality of life. 
This is consistent with our findings on the negative association between unmet health care needs 
and patient satisfaction among patients with neurological conditions.  
Higher education levels and hospital admission through the ER were associated with 
decreased patient satisfaction in our study. This is consistent with findings of other studies (59, 
60), one of which suggests that health care providers may create a better patient experience 
 110 
 
 
through increased communication or more active referral to patient representatives for ER 
patients (59). One other study found that the highest level of education strongly predicted 
favourable satisfaction with communication with doctors (61). This suggests that the negative 
association between highest levels of education and patient satisfaction among individuals with 
neurological conditions in our study may be due to the expectation of communication not being 
met, among neurological patients with higher levels of education.  
The association between ER care in hospitals and lowered patient satisfaction in our 
study may be explained by a reduction in one or more of the components of patient satisfaction 
proposed by Mollaoğlu and Çelik, 2016: guidance, debriefing, paying attention and being kind, 
having empathy, providing psychosocial support, speed of service, timing, proficiency and 
overall quality (62). In addition, severity of patient condition (63) and the stress of a neurological 
patient being in the ER (62) may negatively influence patient’s level of satisfaction with 
emergency services. Given the protective association between high availability of care and 
positive patient satisfaction, lowered odds of patient satisfaction among those who received 
hospital services, particular ER neurological patients, demonstrated in this study, may be 
indicative of decreased availability of care– waiting time too long, care not available when 
requested, care not available in area (few of the elements of unmet health care needs reported in 
the CCHS-2010) (26). 
5.5.1 Strengths and limitations of the study 
One strength of this study is that it supports the finding that unmet health care needs is a 
risk factor for decreased patient satisfaction among those with neurological conditions and that 
availability and quality of care are positive predictors of patient satisfaction across health 
services. Other strengths include the use of a nationally representative survey of the Canadian 
population with relatively high participation rates which allows for generalization in the 
interpretation of the findings; and the provision of information on specific health care services, 
i.e., general health care services, hospital and physician services that may vary in their impact on 
patients with neurological conditions. 
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There are a number of limitations: (1) Persons living on lands designated as Indian 
Reserves or by the Crown, those dwelling in institutions, or in certain remote regions as well as 
full-time members of the Canadian Forces are excluded from this survey Therefore, the data is 
not representative of these groups, especially those residing in institutions, whose information 
would add substantial value to this study. (2) Types of unmet health care needs and neurological 
conditions were not specified, and severity of disease conditions was not measured making it 
difficult to address patient satisfaction within groups of neurological conditions and identify 
specific unmet health care needs for targeted interventions. (3) The use of data from optional 
modules in the survey results in a reduction in the sample size, due to only one province, Ontario 
opting in for modules of interest for this study, decreasing the generalizability of the findings to 
the entire population.  
5.6 Conclusion 
Self-perceived unmet health care needs, as a single variable is a common significant 
negative predictor of neurological patient satisfaction across health care services, while 
availability and quality of care are strong predictors of positive patient satisfaction among the 
same group. Future studies on predictors of neurological patient satisfaction with health care 
services should focus on specific unmet health care needs impacting the different neurological 
conditions and their associations with patient satisfaction. 
People with neurological conditions are known to report unmet health care needs and 
experience barriers to care, limiting their quality of life. Therefore, our study emphasizes the 
importance of ensuring relevant care of the highest quality is available and accessible, especially 
for older Canadians with neurological conditions. This demands a care model that employs a 
coordinated approach assuring access to various types of care needed by Canadians with 
neurological conditions. 
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CHAPTER 6 – AN EXPLORATION OF THE SOCIODEMOGRAPHIC FACTORS AND 
SELECT MEASURES OF SPIRITUALITY/RELIGIOSITY THAT PREDICT GENERAL LIFE 
SATISFACTION AMONG CANADIANS WITH NEUROLOGICAL CONDITIONS LIVING 
IN THE PROVINCES OF NEW BRUNSWICK AND MANITOBA 
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6.1 Abstract 
Background: The symptoms of neurological conditions may affect both patients and caregivers 
leading to substantial reductions in quality of life. Life satisfaction (representing quality of life) 
has been found to be associated with good general and mental health in earlier studies. 
Religion/spirituality have been reported as a source of coping with life difficulties and has been 
associated with improved health outcomes and quality of life domains. Few studies examine the 
effect of religion and spirituality on general life satisfaction among those with neurological 
conditions. Our study aims to examine the sociodemographic factors and select measures of 
spirituality/religiosity that predict general life satisfaction among Canadians with neurological 
conditions. 
Methods: In this study, the Canadian Community Health Survey - Annual Component, 2011 
(CCHS - 2011) was used to perform secondary analyses on a subset of the data, containing 802 
respondents with neurological conditions. Multivariate logistic regression was used to generate 
odds ratios (ORs) and their corresponding confidence intervals for the relationship between 
spiritual and religious factors and other predictors and general life satisfaction. 
Results: The OR for reporting general life satisfaction was lowest among those with: post-
secondary education, 0.83 (95%CI = 0.30-2.30); an annual income of $40,000-$49,000, 0.88 
(95%CI = 0.19-4.07); and spiritual values playing important role in life, 0.53 (95%CI = 0.18-
1.58). The OR for general life satisfaction was highest among those with: an annual income > 
$50,000, 3.44 (95%CI = 0.48-24.61); spiritual strength to face everyday difficulties, 4.65 
(95%CI = 1.13-19.18); regular attendance at religious services, 3.00 (95%CI = 1.07-8.42); very 
good self-perceived mental health, 12.02 (95%CI = 4.40-32.85); and excellent self-perceived 
general health, 17.30 (95%CI = 5.17-57.93). 
Conclusions: We conclude that our findings are consistent with those of previous studies 
indicating that spiritual coping, self-perceived general and mental health are protective predictors 
of life satisfaction and improved quality of life. It may be beneficial to incorporate 
spiritual/religious needs in the circle of care for those living with neurological conditions in 
Canada. 
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6.2 Introduction 
People with neurological conditions are living longer due to many factors (1), which have 
led to increasing focus on quality of life for this population. The progression of some 
neurological conditions may lead to symptoms such as pain, sensory motor symptoms, symptoms 
of movement disturbances, seizures and sensory symptoms (2). These symptoms may affect both 
patients and caregivers leading to substantial reductions in quality of life (2- 4). Life Satisfaction 
has been defined as the “subjective cognitive judgment of one’s quality of life as a whole” (5, 6). 
Life satisfaction (representing quality of life) has been found to be associated with good general 
and mental health (7-10). Several studies examining predictors of mental health have been 
identified in the literature (11-16). Religion/Spirituality is prominently identified as positively 
impacting mental health (17), and life satisfaction (18-21) as it has been used as a resource for 
coping with stress (18, 22). Some studies explain the link between religion/spirituality and 
physical and mental health (23-25). Other studies suggest that embracing religious/spiritual 
values leads to improved general health and quality of life (26-29). Potential explanatory features 
of religiosity/spirituality include “better health practices prescribed by particular religions, lower 
levels of substance use that contribute to negative affect, positive reappraisal of stressful life 
events, more hopeful and positive expectancies and better social support” (30).  
Notwithstanding the many studies that examine the link between religion/spirituality and 
physical health, there are few studies that look at the relationship between elements of 
spirituality and quality of life domains such as general life satisfaction (GLS) among those living 
with neurological conditions, in the Canadian context. Yet, Canada has an increasingly diverse 
population, with a wide cross-section of people who espouse spiritual values (31), with 
approximately three-quarters of Canadians identifying with a religion of some sort or think of 
themselves as members of a specific religious sect or denomination (32). In the same vein, many 
Canadians believe in crucial religious principles such as the existence of God, and divine 
intervention (33). Tate and Forchheimer, 2002, argue that, while spirituality is a construct 
separate from religion, it is related to religion and religiosity, in the sense that religiosity 
describes affiliation with a group that holds specific doctrine and spirituality describes one’s 
relationship to a Supreme Being. Thus an individual may be religious without being spiritual and 
vice versa (34). It is therefore, prudent to examine both related concepts and their associations 
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with quality of life. One Canadian quality of life study which focused on a range of neurological 
conditions found that having a neurological condition affects many areas of life such as general 
and mental health and causes functional impairments that represent a significant reduction in 
quality of life (35). The same study identified that important aspects of spirituality were used as a 
means of coping with neurological conditions. These include a positive attitude and traditional 
spiritual teachings as in the case of First Nations and Métis peoples (35).   
One Italian study explained that different spirituality components, i.e., hope/optimism 
and beliefs, have diverse associations with quality of life, among neurological patients (36), 
while another similar study found that spiritual, religious and personal beliefs (SRPB) factors 
that predicted quality of life were similar in patients with different neurological conditions (37). 
Facets of SRPB (spiritual connectedness, inner peace, awe and openness, inner independence, 
and hope and optimism) jointly predict quality of life, through improved ability to face life 
challenges and difficulties and the capacity to rise above health problems (37). 
Given that many Canadians believe in religious principles, and there is an increasing 
number of Canadians with myriad neurological conditions, it is fitting to examine the impact of 
spiritual values and religiosity on general life satisfaction with a focus on neurological 
conditions. An understanding of the relationship between spiritual values and religiosity on 
general life satisfaction among Canadians with neurological conditions may contribute to the 
Canadian health system’s task of adequately planning, providing for, and meeting the health and 
quality of life needs of this diverse population.  
This study examines the association between spirituality/religiosity and general life 
satisfaction among Canadians with neurological conditions from the 2011 Canadian Community 
Health Survey (CCHS). The objective of this study is to explore the sociodemographic factors 
and select measures of spirituality/religiosity (spiritual values-playing important role in life; 
spiritual values –strength everyday difficulties; and frequency of attendance at religious services) 
as predictors of general life satisfaction (subjective self-judgment of quality of life) among 
Canadians with neurological conditions. 
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6.3 Methods 
6.3.1 Data Sources 
Data were extracted from the Canadian Community Health Survey-Annual Component, 
2011 (CCHS-2011). The target population for this survey includes persons aged 12 and over 
living in private dwellings in all provinces and territories. The survey, excluding participants 
residing in institutions, on Indian Reserves and certain remote regions, and full-time members of 
the Canadian Forces, was conducted between January and December, 2011 using computer 
assisted interviewing (CAI) (38). In addition to the common content answered by all 
respondents, the CCHS-2011 contains optional content which meets the need for information at 
the level of the health regions and is unique to each region or province, varying annually, despite 
being harmonized across the province (38).  
The CCHS-2011 anonymized Master Files were used for this study because it is the latest 
survey containing responses on all major variables of interest in this study: common content on 
general life satisfaction, the one-year unique common content on neurological conditions and the 
optional content on spiritual values (39). Respondents with neurological conditions who reported 
on general life satisfaction and completed the optional module on spiritual values resided in the 
provinces of New Brunswick (NB) and Manitoba (MB), which had a combined population of 1, 
959,439 in 2011. Therefore, for this particular study, a subset of the data, containing 802 
Canadians who reported neurological conditions in the provinces of NB and MB and reported 
spirituality was included in the analysis for this study (see Figure 6-1). Respondents in age 
categories 12-44 years were grouped to protect anonymity, due to the small sample size of the 
study population, and the fact that there were very few people in the youngest age categories 
reporting neurological conditions and spiritual values. 
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Figure 6- 1 Restriction criteria for obtaining sub-sample of CCHS-2011 in this study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Excluded from analysis 
6.3.2 Measures 
6.3.2.1 Assessment of neurological conditions (subpopulation) and general life satisfaction 
(outcome of interest) in CCHS-2011  
Neurological conditions in the CCHS-2010 sample was a derived variable indicating 
whether selected respondents had a neurological condition. The study population for this study 
was selected from selected respondents who stated yes to having a neurological condition from 
among the following list of conditions: AD/dementia, PD, Huntington's disease, Tourette’s 
syndrome, spina bifida, MS, stroke effects, dystonia, epilepsy, cerebral palsy, ALS, muscular 
 Eligible Participants (has 
a neurological condition = 
“yes”) n=8865 
Original CCHS-2010 
Population  
n = 63,542 
 
Final sample with 
neurological conditions 
completing spirituality 
module  
n=802 
 
Has a neurological condition = “no” n 
= 54,677* 
 
Incomplete spirituality 
module n = 8,063* 
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dystrophy, brain injuries, SCI, brain and spinal cord tumors, hydrocephalus, and migraine 
headaches (40).  
The outcome of interest used in this study, General Life Satisfaction (GLS), was derived 
from responses to the question: “Using a scale of 0 to 10, where 0 means "Very dissatisfied" and 
10 means "Very satisfied", how do you feel about your life as a whole right now?” This variable 
groups the 11-point scale to rate respondents’ satisfaction with life into five categories, very 
satisfied, satisfied, neither satisfied nor dissatisfied, dissatisfied and very dissatisfied (40).  
6.3.2.2 Predictors 
We assess the relationship between predictor variables and general life satisfaction. Our 
primary predictor of interest was spiritual values. We selected three variables from the 
spirituality component of the CCHS-2011 survey based upon our objective of identifying if GLS 
is influenced by the importance of spirituality in one’s life, spiritual coping and social religious 
interaction. These elements were identified by the following questions: 
(1) Importance of spirituality: Do spiritual values play an important role in your life? 
Responses were coded, “yes” = 1 and “no” = 0.  
(2) Spiritual coping: To what extent do your spiritual values give you the strength to face 
everyday difficulties? For the purpose of this study, the question was interpreted as “do 
spiritual values give you strength to face everyday difficulties”? Response categories 
were collapsed and recoded as follows: “yes” = 1, a combination of the responses “a lot” 
and “some” and “no” = 2, a combination of “a little” and “not at all”.  
(3) Social religious interaction: “Not counting events such as weddings or funerals, during 
the past 12 months, how often did you participate in religious activities or attend religious 
services or meetings?” Response categories were collapsed and coded as follows: “not at 
all” = 0; “regular” (at least once a week/at least once a month) = 1; and “irregular” (at 
least three times a year/once or twice a year) = 2 
The following represent other predictors and covariates of GLS that were included in our 
analyses:  
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Age (< 45, 45-64, 65-79, 80+ years),   
Sex (“male” = 0 vs “female” =1),  
Marital status (“married/common-law”, “widowed/divorced/separated”, “single/never 
married”),  
Level of education (“less than secondary”, secondary graduation”, “post-secondary 
graduation”),  
Total personal income from all sources in Canadian dollars (less than 19,999, 20,000-
39,999, 40,000-49,999, 50,000 or more),  
Self-perceived health (“poor”, “good”, “very good”),  
Self-perceived mental health (“poor”, “good”, “very good”). 
Variables that included categories indicated as “do not know”, “refusal” and “not stated” were 
recoded as (“.”) and treated as missing values.  
6.3.3 Statistical Analyses 
Analysis of the data found in the CCHS-2011 was completed using STATA version 14 
on restricted confidential master data files accessed through the Saskatchewan Research Data 
Center at the University of Saskatchewan (https://crdcn.org). Due to this restricted access, there 
are limitations on the release of data. To account for survey design, weighted analysis was 
completed by applying sampling weights to our data set. We did not apply bootstrapping due to 
the very small sample size of our study population. We generated descriptive frequencies for the 
socio-demographic characteristics (age, gender, marital status, education, and personal income), 
spiritual values variables, self-perceived health, and self-perceived mental health. Due to the 
many missing variables across all variables, we performed multiple imputation to prevent 
selection bias and loss of information. Imputed values were included in the analysis.  
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Logistic regression was used to estimate the association between predictor variables and 
general life satisfaction because the assumptions for ordered logistic regression are violated. The 
outcome variable categories 1 and 2 were collapsed and recoded as “satisfied” = 1, while 
categories 3-5 were collapsed and recoded as “dissatisfied” = 0 (39) and logistic regression 
conducted because generalized ordered logistic regression models would not converge in the 
model building process. 
Screening of selected variables was done by examining unconditional associations 
between each predictor and the outcome of interest (GLS), with liberal p-values set at p<0.20. 
Unadjusted odds ratios (UOR) and 95% confidence intervals (CI) were reported. All variables 
with a p-value <0.20 in the univariate analyses were retained for further use in multivariate 
analysis.  
A manual backward elimination strategy was used to remove variables with p-values 
>0.05 in the multivariate model building process. All variables with significant p-values ≤0.05 
were retained in the final model. Eliminated variables that had an initial significant p-value at 
unconditional analysis were checked for confounding and interaction and retained in the final 
model if they demonstrated interaction with or altered the coefficients for any exposure of 
interest by >20%. The final model was analyzed using multivariate logistic regression. Adjusted 
odds ratios (AORs) and 95% confidence intervals (CI) were generated and interpreted to 
demonstrate the association between spiritual values and other predictors and general life 
satisfaction. A likelihood ratio test was performed to check the overall significance of this 
multivariate logistic regression model. 
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6.4 Results 
6.4.1 Characteristics of the study population – individuals with neurological conditions  
 Participants who did not report neurological conditions or complete the optional module 
on spiritual values were excluded from our analysis. Therefore, the final weighted subsample 
contained a total number of 4, 562 individuals with neurological conditions who responded to the 
spiritual values component of the restricted access CCHS-2011. Majority of respondents were 
females (60.4%), while approximately half were 44 years of age or younger (50.4%), married or 
in common-law unions (46.5%) and earned less than $20, 000 annually (46.1%). Most people 
were satisfied with life in general (84.5%), while a little more than one-third had less than 
secondary education (38.5%). A smaller number of respondents reported spirituality playing an 
important role is life (38.9) than those for whom it did not play an important role (61.1%). 
Almost 75% depended on spiritual values for strengths to face everyday difficulties (74.8%), 
while half of the respondents did not attend religious services ((50.5%). Table 6-1 below shows 
the demographic features of the study population, including perceived health status and 
spirituality characteristics. Total number of cases vary due to missing values which were imputed 
for further analysis. 
Table 6- 1 Sociodemographic and other characteristics of study population 
Characteristics Frequency (n) Percentage (%) 
Age categories, years   
≤44 years  2301 50.4 
45 to 64  1262 27.7 
65 to 79  612 13.4 
80 and above 387 8.5 
Sex   
Male 1809 39.6 
Female 2753 60.4 
Marital Status   
single 1555 34.1 
Married/common-law 2121 46.5 
widowed/separated/divorced 884 19.4 
Level of Education   
<secondary 1752 38.5 
secondary grad 1051 23.1 
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post-sec grad 1746 38.4 
Personal income   
<=19,999 2055 46.1 
20,000-39,999 1278 28.7 
40,000-49,999 385 8.6 
>=50,000 738 16.6 
General Life Satisfaction   
Dissatisfied 689 15.2 
Satisfied 3828 84.8 
Spiritual values –playing imp role in life   
No  2761 61.1 
Yes 1756 38.9 
Spiritual values –strength everyday difficulties   
No  1076 25.2 
Yes 3196 74.8 
Frequency of attendance at religious services   
Not at all 1914 50.5 
Regular 980 25.8 
irregular 897 23.7 
Self-perceived health   
Poor 1281 28.1 
Good 1485 32.5 
Very good 1796 39.4 
Self-perceived mental health   
Poor 569 12.6 
good  1417 31.3 
Very good 1595 35.2 
excellent 949 20.9 
 
6.4.2 Characteristics associated with general life satisfaction among individuals with 
neurological conditions (univariate analysis) 
 Table 6-2 reports the unadjusted Odds Ratio (OR) of general life satisfaction by each 
predictor in our study. Age, sex and marital status were insignificant negative predictors (p = 
0.157; 0.078; and 0.112, respectively) of GLS. The unadjusted odds of reporting general life 
satisfaction decreased with age, with individuals 45-64 being, 0.54 (95%CI = 0.24-1.27) times 
less likely to report satisfaction with life in general, than those 44 years of age or younger and 
were 0.42 (95%CI = 0.16-1.10) times lower in the 65-79 age category and 0.44 (95%CI = 0.16-
1.21) times lower in the 80+ age category. Females were less likely (OR = 0.82, 95%CI 0.39-
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1.74) than males to be satisfied with life in general, while those who were widowed, separated or 
divorced had the lowest chance (OR = 0.56, 95%CI 0.19-1.64) of reporting satisfaction with life 
in general while those who were married and in common law relationships were 0.99 (95%CI = 
0.39-2.50) times less likely to be satisfied with life in general than those who were single.  
 Protective predictors of general life satisfaction were education, income, spiritual values- 
playing an important role is life, spiritual values-strength to face everyday difficulties, frequency 
of attendance at religious services, self-perceived health and self-perceived mental health. The 
odds of general life satisfaction increased with levels of education, with the unadjusted odds of 
satisfaction 1.23 (95%CI = 0.50-3.05) times higher in secondary graduates and 2.50 (95%CI = 
1.18-5.32) times higher in post-secondary graduates when compared to those with less than 
secondary education. Similarly, unadjusted odds of GLS increased with income, with the 
unadjusted odds of GLS being 9.29 (95%CI = 1.60-53.83) times significantly higher among 
those with an annual personal income of $50,000 or more.  
 Those who reported spiritual values-playing an important role in life were 1.05 (95%CI = 
0.50-2.20) times more likely to be satisfied with life in general compared to those to whom it 
was not important, while those who reported spiritual values providing strength for everyday 
difficulties were 2.18 times more likely to be satisfied with life in general compared to those who 
did not report spiritual values providing strength for everyday difficulties. The unadjusted odds 
of general life satisfaction increased with frequency of attendance at religious services, with the 
unadjusted odds of GLS being 1.65 (95%CI = 0.63-4.28) times higher among those reporting 
irregular attendance and 2.78 (95%CI = 1.28-6.03) times significantly higher among those 
attending regularly compared to those who did not attend at all. 
 In a similar thread, the unadjusted odds of being satisfied with life in general significantly 
increased with increasing self-perceived health. Those reporting good self-perceived health were 
4.02 (95%CI = 1.59-10.17) times more likely to be satisfied than those who reported poor self-
perceived health, and those with very good health 22.10 (95%CI = 9.33-52.31) times more likely 
to be satisfied than those with poor self-perceived health. On the other hand, self-perceived 
mental health was the strongest significant protective predictor of general life satisfaction, with 
increasing unadjusted odds of GLS with increased self-perceived mental health. Compared to 
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those who reported poor self-perceived mental health, unadjusted odds of GLS were 7.75 
(95%CI = 2.82-21.40) times higher among those reporting good self-perceived health, 
16.14(95%CI = 6.28-41.52) times higher among those reporting very good self-perceived health 
and 21.88 (95%CI = 6.64-72.05) times higher among those reporting excellent self-perceived 
health. 
Table 6- 2 Univariate analysis of predictors of general life satisfaction among individuals with 
neurological conditions 
Characteristics OR  95% CI p-Value 
Age categories, years    
≤44 years  Reference   
45 to 64  0.54 0.24-1.27 0.157 
65 to 79  0.42 0.16-1.10 0.078 
80 and above 0.44 0.16-1.21 0.112 
Sex    
Male Reference   
Female 0.82 0.39-1.74 0.605 
Marital Status    
Single Reference   
Married/common-law 0.99 0.39-2.50 0.981 
widowed/separated/divorced 0.56 0.19-1.64 0.286 
Level of education    
<secondary Reference   
secondary grad 1.23 0.50-3.05 0.646 
post-sec grad 2.50 1.18-5.32 0.018 
Personal income    
<=19,999 Reference   
20,000-39,999 1.58 0.73-3.42 0.246 
40,000-49,999 3.17 0.97-10.33 0.055 
>=50,000 9.29 1.60-53.83 0.015 
Spiritual values –playing imp role in life    
No  Reference  Reference 
Yes 1.05 0.50-2.20 0.893 
Spiritual values –strength everyday 
difficulties 
   
No  Reference  Reference 
Yes 2.18 0.76-6.29 0.142 
Frequency of attendance at religious 
services 
   
Not at all Reference  Reference 
Regular 2.78 1.28-6.03 0.010 
irregular 1.65 0.63-4.28 0.305 
Self-perceived health    
Poor Reference  Reference 
good  4.02 1.59-10.17 0.003 
Very good 22.10 9.33-52.31 <0.001 
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Self-perceived mental health     
poor Reference  Reference 
good 7.75 2.82-21.40 <0.001 
Very good 16.14 6.28-41.52 <0.001 
excellent 21.88 6.64-72.05 <0.001 
6.4.3 Characteristics associated with general life satisfaction among individuals with 
neurological conditions (multivariate analysis) 
All the variables with a (p >0 .20) that were excluded in the initial multivariate logistics 
regression model building process were included in the final multivariate due to presence of 
confounding and/or interaction with the primary predictor variables of interest. Our study 
produced the adjusted odds ratios (AORs), estimates of the relationship between 
sociodemographic characteristics, self-perceived health (mental and physical), spiritual values 
and general life satisfaction, among individuals with neurological conditions. Table 6-3 below 
presents the results of the final multivariate logistic regression model for GLS with adjusted 
predictor variables.  
Table 6- 3 Multivariate analysis of predictors of general life satisfaction among individuals with 
neurological conditions 
Characteristics AOR  95% CI p-Value 
Age categories, years    
≤44 years  Reference   
45 to 64  0.65 0.22-1.92 0.434 
65 to 79  0.37 0.11-1.31 0.122 
80 and above 0.39 0.09-1.75 0.217 
Sex    
Male Reference   
Female 0.54 0.22-1.34 0.182 
Marital Status    
single Reference   
Married/common-law 1.94 0.57-6.59 0.287 
widowed/separated/divorced 1.29 0.37-4.47 0.687 
Level of education    
<secondary Reference   
secondary grad 0.65 0.22-1.96 0.445 
post-sec grad 0.83 0.30-2.30 0.723 
Personal income    
<=19,999 Reference   
20,000-39,999 1.07 0.40-2.90 0.883 
40,000-49,999 0.88 0.19-4.07 0.875 
>=50,000 3.44 0.48-24.61 0.210 
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Spiritual values –playing imp role in life    
No  Reference   
Yes 0.53 0.18-1.58 0.252 
Spiritual values –strength everyday 
difficulties 
   
No  Reference   
Yes 4.65 1.13-19.18 0.035 
Frequency of attendance at religious 
services 
   
Not at all Reference   
Regular 3.00 1.07-8.42 0.037 
irregular 1.42 0.48-4.17 0.528 
Self-perceived health    
Poor Reference   
good  2.62 1.06-6.49 0.037 
Very good 8.81 2.65-29.34 <0.001 
Self-perceived mental health     
Poor Reference   
Good 12.02 4.40-32.85 <0.001 
Very good 9.82 3.87-24.89 <0.001 
excellent 17.30 5.17-57.93 <0.001 
 
 Our study found that there were negative insignificant associations between GLS and 
age, sex, education, annual personal income of $40,000-$49,000, and spiritual values playing 
important role in life. The association between age and GLS was decreased in those aged 45+, 
compared to those 44years of age or below, with the 65-79 age category demonstrating 0.37 
(95%CI = 0.11-1.31) times less adjusted odds of reporting GLS, while the 80+ age category was 
0.39 (95%CI = 0.09-1.75) times less likely to report GLS, and those 45-64, 0.65 (95%CI = 0.22-
1.92) times less likely to report GLS. Females reported 0.54 (95%CI = 0.22-1.34) times lower 
odds of GLS compared to males. 
 The adjusted odds of reporting satisfaction with life in general was 0.83 (95%CI = 0.30-
2.30) times lower with the highest level of education, post-secondary education and 0.65 (95%CI 
= 0.22-1.96) times lower with secondary education when compared to less than secondary 
education. Earning an annual income of $40,000-$49,000 was associated with 0.88 (95%CI = 
0.19-4.07) times lower adjusted odds of GLS when compared to those who earned less than 
$19,999 personal income annually. On the other hand, earning $20,000-$39,000 was associated 
with 1.07 (95%CI = 0.40-2.90) times higher adjusted odds of GLS, while earning $50,000 or 
more in personal income annually was associated with 3.44 (95%CI = 0.48-24.61) higher 
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adjusted odds of GLS. When contrasted with the opposite group, those who found spiritual 
values playing important role in life reported a 0.53 (95%CI = 0.18-1.58) times lower adjusted 
odds of GLS. 
 We found spiritual values providing strength to face everyday difficulties, regular 
attendance at religious services and self-perceived physical and mental health to be significant 
protective predictors of GLS. Those who used spiritual strength to face everyday difficulties 
reported a 4.65 (95%CI = 1.13-19.18) times significantly higher adjusted odds of GLS, when 
compared to those who did not. When compared to those who did not attend religious services at 
all, the adjusted odds of GLS were 1.42 (95%CI = 0.48-4.17) times higher in those who attended 
irregularly and 3.00 (95%CI = 1.07-8.42) times significantly higher in those who attended 
religious services regularly. 
 The adjusted odds of GLS were significantly higher with increased ratings of self-
perceived health. When compared to poor self-perceived health, the adjusted odds of GLS were 
2.62 (95%CI = 1.06-6.49) times higher with good health and 8.81 (95%CI = 2.65-29.34) times 
higher with very good health. At the same time, when compared to poor self-perceived mental 
health, the adjusted odds of GLS were 9.82 (95%CI = 3.87-24.89) times higher with very good 
self-perceived mental health, 12.02 (95%CI = 4.40-32.85) times higher with good self-perceived 
health and 17.30 (95%CI = 5.17-57.93) times higher with excellent self-perceived health. 
6.5 Discussion 
 Our study demonstrates that spirituality and religiosity, as well as self-perceived health 
and self-perceived mental health were significantly associated with GLS while spiritual values 
playing important role in life was associated with lower odds of GLS. Additionally, marital 
status and incomes greater than $50,000 and between $20,000 - $39,999 demonstrated 
insignificant positive associations with satisfaction with life in general. On the other hand, age, 
sex (female), income levels between $40,000-$49,000 and education also demonstrated negative 
associations with GLS, although these associations were not significant. 
 Our findings on the protective associations between elements of spirituality and GLS, 
support that of an earlier study which examined the impact of spirituality on life satisfaction 
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among patients with cancer and spinal cord injury (34). That study found that life satisfaction 
was influenced by one’s spiritual well-being and was more closely related to inner experiences 
than physical restrictions (34). In another study that sought to determine if spirituality facilitates 
resilience and adjustments of individuals after spinal cord injury, the authors describe spirituality 
as not necessarily related to religiosity and encompasses the ability to rise above life’s 
circumstances (41). Our study supports this concept, providing evidence that spiritual values-
strength to face everyday difficulties was strongly correlated with GLS in those with 
neurological conditions. Furthermore, similar to the findings of another Canadian study (37), 
spiritual values as important to everyday life on its own was not a protective predictor of GLS, 
suggesting that it is the meaning to life and the coping mechanism and resilience (42-44) 
provided through the spiritual source of strength (45) that makes the difference in GLS for those 
with chronic illnesses, including neurological conditions.  
 Despite not examining support networks, social contacts and social studies in relation to 
spirituality in this study, we discuss our findings according to that found in other studies. We 
theorize that the strong positive association between regular attendance at religious services and 
GLS in our study is similar to the positive association between life satisfaction and the amount 
and quality of social interactions found in quality of life studies on cancer patients (46-48). This 
association between GLS and regular attendance at religious services may be explained by 
regular positive social interactions with individuals who share similar beliefs. One study 
focusing on older adults found positive associations between the employment of religious coping 
skills and religious support and greater life satisfaction (49). Other much earlier studies on 
impairments, disability and spinal cord injury support our theory; reporting greater life 
satisfaction in those who make deliberate attempts at maintaining customary social connections, 
have more involvement in general life activities and greater capacity to navigate their 
surroundings (50-52). On the other hand, regular church attendance, an element of religiosity 
(53) may be an outward expression of the depth of one’s spirituality (54) or relationship with a 
Supreme being (55), further supporting our finding that frequency of religious attendance, as an 
element of spirituality in itself, is positively correlated with GLS. Overall, spiritual coping, i.e., 
spiritual values-strength for everyday difficulties, has a distinctive role in promoting GLS among 
those with neurological conditions (18). 
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 Our finding that self-perceived physical and mental health are protective predictors of 
GLS is well established in several studies (56- 59). Increasing ratings of self-reported general 
and mental health being strongly correlated with life satisfaction in patients with neurological 
conditions is supported in other studies of patients with chronic musculoskeletal pain (58) and 
other chronic conditions (60, 61). These associations can be explained by the impact of physical 
and mental problems connected to neurological conditions on self-perceived ratings of general 
and mental health (62). Those with neurological conditions may have lower self-perceived 
general and mental health, when their conditions compromise their physical and mental 
functionality, leading to decreased life satisfaction (63). The converse may be true, that when 
they feel better about their physical and mental health, those with neurological conditions are 
more satisfied with life in general.   
Social integration, social roles and their importance to health status and quality of life 
have been emphasized in different studies and point to the need for consistent social ties, 
companionship, intimacy and support for well-being and life functioning (64, 65). Respondents 
with neurological conditions, who were in marriage and common-law relationships, were found 
in our study to be more likely to be satisfied with life in general than those who had never been 
married and those who were single due to being widowed, divorced or separated. This finding 
reported in other studies (34 & 58), is likely explained by the benefits of social integration, one 
of which is having a proximate adult to depend on when coping with chronic conditions (66). 
We found that highest levels of income ($50,000 or more) demonstrated a positive 
correlation with GLS, providing supportive evidence for previous studies (57, 67-70). To the 
contrary, lower levels of income ($40,000 to $49,000) demonstrating a negative association with 
GLS is possibly due to decreased ability to afford medications (71). On the other hand, 
increasing age for the participants in our study, could mean greater disability associated with 
neurological conditions and may be synonymous to the disintegration of life, including loss of 
independence and participation in social activities (72, 73), explaining the negative association 
between older age categories and GLS.  
Higher levels of education negatively associated with GLS adds to the conflicting 
literature on this matter (58, 74, 75). The subjectivity of life satisfaction as a measure of one’s 
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own quality of life as well as the different measures of life satisfaction employed in other studies 
may explain the contradictory relationship between education and GLS. Additionally, education 
is known to improve one’s chances of better health, earning potential and career possibilities 
(76). The loss of these abilities due to the debilitating effects of neurological conditions may lead 
to a lowered estimation of GLS among those with higher levels of education in this study. We 
propose that higher levels of education associated with decreasing GLS found in our study may 
be linked to the ability to hold a job which is a common psychosocial difficulty among 
individuals with neurological conditions (77, 78). Nonetheless, the role of education in life 
satisfaction is not broadly investigated and not well understood (79, 80). 
6.5.1 Strengths and limitations of the current study 
The major strength of our study is that it adds to the literature on life satisfaction and 
neurological conditions, reporting positive findings consistent with spirituality, self-perceived 
general and mental health and other predictors of life satisfaction. There are several limitations: 
the small sample size from this cross-sectional study hinders the representativeness of our 
sample and limits causality and determination of the directionality of the predictors and life 
satisfaction; exclusion of participants living in institutions , and the inability to rule out a possible 
selection bias of individuals who were functionally capable of responding the questionnaires (81) 
may reduce the generalizability of our study. 
6.6 Conclusion 
Our findings provide added evidence that spiritual coping (spiritual values-strength for everyday 
difficulties) and regular attendance at religious services, self-perceived health and self-perceived 
mental health are protective predictors of general life satisfaction, a subjective measure of one’s 
quality of life. Individuals with neurological conditions to whom it may be relevant, would 
benefit, in alignment with their personal beliefs, from the employment of spiritual and religious 
resources that have been linked with better management of chronic conditions, for improved 
quality of life. More research is needed on the severity of disease of specific neurological 
conditions and specific psychosocial factors of general life satisfaction (e.g., social support and 
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social interaction) among the highly educated within older age categories and accounting for sex 
difference. 
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CHAPTER 7: CONCLUSION, PRACTICAL IMPLICATIONS AND FUTURE RESEARCH 
The Canadian National Population Health Study of Neurological Conditions present a 
grave picture of the burden of the neurological conditions examined in this study, indicating that 
the burden is indeed high and will get higher as the Canadian population ages (1). Most 
neurological conditions are accompanied by severe symptoms that affect the quality of life of 
patients especially as diseases progress and with age (2). Some of the neurological conditions in 
this study (PD, MS, epilepsy, stroke effects, migraine) are associated with higher prevalence and 
huge costs in developed countries (3). This along with the fact that the global DALYs associated 
with neurological conditions is on the increase and is attributable to the aging population (4-6), 
presents a significant economic burden to a country like Canada whose older population is 
rapidly growing and whose health system is supported by the public purse. To ensure equities in 
service across the continuum of care, major investments are required to equip the health system 
to meet the needs of the increasing population of people with neurological conditions. 
There is a dire shortage of health care workers in general, with gaps in training for care of 
the elderly (7, 8). Furthermore, high-income countries including Canada, report shortages of 
neurologists. As the population ages and people live longer with PD, AD/dementia and other 
neurological conditions, the challenge of access to relevant and quality care will likely worsen 
(9). The increasing prevalence of neurological conditions with reduced incidence year over year 
as is reported in some high-income countries, will be hard to navigate with a shortage of 
neurologists who may not have experience in diagnosing common conditions such as PD and 
AD/dementia (10). The long wait times for initial diagnostic consultations compounds the 
problem of misdiagnosis before the more progressive states of disease (11). In light of the 
increasing prevalence, larger numbers of people 65+ living in the population at risk of the 
debilitating effects of neurological conditions, a major consideration in health systems planning 
in Canada is equitable access to care. In fact, common care inequalities that have been reported 
among those with neurological conditions in high-income countries include: poor access to and 
long waits to see neurologists and other specialists including therapists, and mental health and 
social care support workers (12). 
 143 
 
 
The Canadian’s health care system is designed to provide acute care in a rapidly changing 
clinical environment (13). These acute health care settings can be difficult for people with NC to 
navigate as the pace of care can aggravate symptoms associated with NC. For example, in 
AD/dementia, increasing disorientation and confusion (14), may lead to health care providers 
overlooking and exacerbating psychosocial needs. (15). The multiple psychosocial difficulties 
and unmet needs associated with NC impact health care utilization, and quality of life including 
self-reported health. As the impacts of NC is not confined to patients and their families, but 
extend to the broader communities and the health system, managing NC amidst the aging 
population is a public health concern. The common function of public health systems is to 
prevent disease and promote health (16).  The Canadian health system operates on the universal 
health care model, 70% of which is funded by tax-payers’ resources (17). These resources are 
limited in view of the responsibilities to the population in fulfilling the core functions of public 
health: policy development and program evaluation, health human resource planning, public 
education and awareness, exploring health risks and conducting research, tracking health status, 
community engagement, linking patients to health services and operating within laws and 
regulations (16). Given that almost ¾ of health spending comes from the public purse, the rising 
prevalence of NC and attendant psychosocial difficulties , in the midst of a growing older 
population, will result in a greater strain on the government’s budget (18) as well as higher out of 
pocket expenses for neurological patients. 
Population-based research on neurological conditions is vital to ensure that public health 
policy and planning of programs are informed by current information on risk factors, trends, and 
quality of life indicators of positive patient outcomes. These principles are embedded in this 
thesis which examines several areas of neurological conditions research, with studies focusing on 
select conditions, either independently or collectively. The first objective was to understand the 
relationship between an established risk factor, toxic occupational exposures (electromagnetic 
fields, metals and pesticides), and the development of Parkinson’s disease. The second identified 
trends in Alzheimer’s disease/dementia prevalence by age, gender, education and geographic 
regions while the third assessed the relationship between self-reported unmet care needs and 
other predictors of satisfaction with general health care, physician, and hospital services among 
Canadians with an assortment of neurological conditions. Finally, the effects of 
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sociodemographic factors, physical and mental health and spirituality on general life satisfaction 
were examined among Canadians with a mixture of neurological conditions. The relevance of the 
findings to public health policy, planning and decision-making for the improved quality of life of 
this vulnerable population within Canada is discussed in this chapter. 
7.1 Summary of Major Findings 
In chapter 3 of this thesis, we performed a review and meta-analysis of the existing 
literature to examine the relationship between specific toxic occupational exposures (which have 
been previously identified as environmental risk factors) and the development of PD. Earlier 
studies present evidence of a definite association between pesticide exposure and PD and 
conflicting associations between exposure to electromagnetic fields and metals and PD 
development. However, most of those studies employed cross-sectional designs or did not 
discriminate between those designs and longitudinal cohort designs. The interpretation of 
causality for those studies is therefore, limited. In this study, our main goals were to ascertain the 
risk of PD attributable to overall toxic occupational exposures, and electromagnetic, metal and 
pesticide exposures and understand the relationship between toxic occupational exposures and 
PD by diagnostic methods. The study focused on longitudinal cohort designs which are more 
advantageous in determining relative risk. 
Twenty-four articles met our inclusion criteria. However, as some studies identified more 
than one exposure of interest included in our study, a total of 35 studies were included in our 
analysis. The pooled RR between any type of toxic occupational exposure and PD was 1.15 
(95% CI 1.06-1.24). For the individual types of toxic occupational exposures and their 
associations with PD, the RRs were: electromagnetic exposure, 1.03 (95% CI 0.91-1.16); metal 
exposure, 1.07 (95% CI 0.92-1.24); and pesticide exposure,1.41 (95% CI 1.06-1.65). The pooled 
RRs for the relationship between toxic occupational exposures and PD by method of diagnoses 
were: confirmation by neurologist or nurse, 2.17 (95% CI 1.32-3.54); medical records, 1.06 
(95% CI 0.92-1.21), and ICD codes, 1.14 (95% CI 1.03-1.26). 
Our systematic review and meta-analysis provide solid evidence to support the 
hypothesis that toxic occupational exposures as a whole is a major environmental risk factor for 
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PD. This is the first study to our knowledge that demonstrates associations between toxic 
occupational exposures by method of PD diagnosis. It demonstrates that the strongest association 
between any toxic occupational exposure and PD was that confirmed by a neurologist or nurse. It 
is clear that using a reliable standardized approach by a specialist is important for the accurate 
confirmation of PD and establishing accurate estimates of risk of PD through toxic occupational 
exposures. The evidence provided by this review supports the need for public health strategies 
and prevention programs aimed at reducing the risk of PD and a targeted approach to ensuring 
protection against environmental exposure to occupational toxins.  
Chapter 4 of this thesis provides nationally representative community-based prevalence 
estimates of Alzheimer’s disease/dementia by sociodemographic factors (age, sex, education and 
region of residence) of Canadians over a twenty-year period (1994-2014). Given the projected 
impacts of an aging Canadian population and the economic and psychosocial burden on 
AD/dementia patients, their caregivers, and the health system in general, increasing prevalence 
of AD/dementia is a major concern worldwide. Accurate and updated estimates of these 
progressively severe conditions are required for effective health care systems planning, and 
policy decisions. There is a dearth of research on Alzheimer’s/dementia trends using Canadian 
data. We used the NPHS biannual components and the CCHS annual components to identify 
changes in overall AD/dementia prevalence over a period of twenty years, and to examine 
differences in prevalence estimates among individuals age 45+, according to their sex, levels of 
education and regions of residence on Canada. 
The prevalence of AD/dementia, standardized by age and sex to the 2001 Canadian 
population census, increased with age in both men and women across all age categories but 
increased significantly after age 80 and over time. There was a greater increase in prevalence 
among men than women. The standardized (2001 Canadian population census) prevalence of 
AD/dementia among Canadians 45 years or older was 0.14% in 1994 and 0.80% in 2014, an 
overall 0.66 percentage point increase in AD/dementia between 1994-2014. There was a 0.83% 
increase in prevalence of AD/dementia among the 65-79 age groups and a 4.29 % increase 
among those 80+ years of age. We did not observe a significant geographic difference in 
prevalence of AD/dementia over the years, while lower increases in prevalence were recorded 
among Canadians with higher levels of educational attainment. 
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Consistent with other prevalence studies on Alzheimer’s disease/dementia conducted in 
developed countries, this study provides evidence of an increase in prevalence of AD/dementia. 
This increase appeared to be across all strata in the community in Canada, and mostly among 
men aged 65 or older, and those with lower levels of educational attainment. Our findings 
underscore the need for health system capacity strengthening and preparation for increasing 
challenges associated with long-term care of AD/dementia including rising costs, caregiver 
burden and increased demand for neurologists’ services. As well, prevention strategies that focus 
on minimizing risk (behavior modification programs, reduced exposure to environmental factors) 
and enhancing protection (higher levels of education, positive social interaction) are required. 
In chapter 5, we conducted multivariate logistic regression modelling to explore unmet 
health care needs and other predictors of patient satisfaction with general health care services, 
hospital and physician services among Canadians with neurological conditions. A serious 
concern of patients with neurological conditions is the psychosocial difficulties that they 
navigate especially for those with progressive long term conditions. They may not always have 
equal or easy access to the care that they need. Patient satisfaction has been used as a measure of 
health care utilization and has been associated with health-related quality of life. An 
understanding of the relationship between unmet health care needs and patient satisfaction with 
health services among older Canadians with neurological conditions is crucial in the ongoing 
evaluation and resulting continuous quality improvement of healthcare services available for this 
portion of the population dealing with debilitating effects of their conditions. We developed a 
research model of health care utilization based on Andersen’s health behavior model to predict 
patient satisfaction with the three types of health services. 
We found that significant protective predictors of patient satisfaction with health care 
services in general are quality and availability of provincial and received care, and being very 
satisfied with life in general. Quality of care was strongly and positively associated with patient 
satisfaction across all health services. In contrast, the common significant negative predictor of 
patient satisfaction across all health care services was self-perceived unmet health care needs in 
this study. People with neurological conditions, because of their attendant disabilities, are known 
to report unmet health care needs and experience barriers to care, limiting their quality of life. 
Our study emphasizes the importance of ensuring available and accessible quality care and the 
 147 
 
 
increased need for coordinated services that improve patient satisfaction, better health outcomes, 
and the health-related quality of life for Canadians with neurological conditions. 
Finally, chapter 6 of this thesis examined the association between spirituality/religiosity 
and general life satisfaction among Canadians with neurological conditions from the 2011 
Canadian Community Health Survey (CCHS). Spirituality has been reported in multiple studies 
to be associated with better physical health outcomes, but not many studies have examined the 
link between spirituality and quality of life domains such as satisfaction with life in general 
among a group of people living with select neurological conditions. Our objective in this study 
was to explore the sociodemographic factors and select measures of spirituality/religiosity 
(spiritual values-playing important role in life; spiritual values –strength everyday difficulties; 
and frequency of attendance at religious services) as predictors of general life satisfaction 
(subjective self-judgment of quality of life) among Canadians with neurological conditions. 
We found spiritual values providing strength to face everyday difficulties, regular 
attendance at religious services and self-perceived physical and mental health to be significant 
protective predictors of satisfaction with life in general. Of particular interest, was the finding 
that, when compared to those who did not, those who used spiritual strength to face everyday 
difficulties were 4.65 (95%CI = 1.13-19.18) times more likely to be satisfied with life in general, 
while those who attended religious services regularly were 3.00 (95%CI = 1.07-8.42) times more 
likely to be satisfied with life in general than those who did not attend religious services at all. In 
terms of health status, the odds of satisfaction with life in general were significantly higher with 
increased ratings of self-perceived health and mental health. Socio-demographic variables were 
not significant predictors of general life satisfaction, though being married was associated with 
greater odd of satisfaction with life in general, and surprisingly higher levels of education were 
associated with lowered odds of general life satisfaction among those with neurological 
conditions in the community in Canada. 
Our findings provide additional evidence that spiritual coping (spiritual values-strength 
for everyday difficulties) and regular attendance at religious services, self-perceived health and 
self-perceived mental health are associated with general life satisfaction, a subjective measure of 
one’s quality of life. Given Canada’s diverse population with multiple religious’ persuasions and 
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concepts of spirituality, it is fitting, where relevant to patients’ personal beliefs, to incorporate 
spiritual and religious resources that have been linked to positive health outcomes in managing 
the care of those with neurological conditions. 
7.2 Practical Implications and Future Research 
The findings of our study have important implications for public health prevention 
strategies and health services planning. The risk factors, trends, and predictors of domains of 
quality of life among those with neurological conditions confirmed in our study indicate the need 
for continued dialogue and research in preparation for the projected growth and shift in the age 
structure to more people in the 65+ age category in the Canadian population by 2031. The 
significant associations between toxic occupational exposures and Parkinson’s disease , found in 
our systematic review indicate the necessity for public campaigns regarding protection against 
occupational environmental risk factors such as electromagnetic fields, metals and more 
importantly, exposures to pesticides. Also, the significant association between diagnosis of PD 
using standardized methods by a neurologist or nurse and toxic occupational exposures 
underscores the need for standard education of neurologists and other specialists on the 
diagnostic methods of the condition.  
Rising prevalence of AD/dementia in the community suggests the need for targeted 
population-based public health prevention and promotion programs as well as health systems 
planning for long-term care due to the progressive nature of the disease. As more males are 
living with AD/dementia than females in the community, it’s important that while population-
based secondary prevention programs, that focus on their psychosocial needs and providing 
adequate access to resources, are being developed, some attention is paid to the needs of men 
that may differ from those of women. 
Though this thesis does not itemize specific unmet health care needs reported by those 
with NC, its strong negative association with patient satisfaction is cause for concern. There is 
some indication from our study findings that receiving services at the ER reduces patient 
satisfaction. As the availability and quality care are predictors of patient satisfaction, which is 
correlated with positive health outcomes, the design of health services that promote the concept 
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of a circle of care, that ensures relevant services that meet patients’ needs, becomes a necessary 
addition to the continuum of care for improved quality of life for patients with neurological 
conditions. 
Life satisfaction as a subjective indicator of quality of life is predicted by higher levels of 
self-perceived physical and mental health and spiritual values, demonstrated in strength to cope 
with difficulties and regular attendance at religious services in our study. These findings 
highlight the need for public health interventions that assume a multipronged approach that 
focuses on alleviating psychosocial difficulties and helping to create a positive outlook in those 
struggling with neurological conditions. This means that policies are needed to govern 
accommodation of religious practices and the incorporation of spiritual needs in aspects of care 
provided to neurological patients. 
The increase in the number of people affected by neurological conditions signifies the 
need for increased resources targeted to effective management that promotes quality of life. 
Understanding the prevalence of neurological conditions allows for prioritizing financial 
resources to support health services and also facilitates human resource planning. For, e.g. 
knowing the challenges to and the predictors of domains of quality of life among those with 
neurological conditions allows for planning and coordinating health and social services that are 
common to neurological conditions that are easily accessible. Apart from the viewpoints on 
public health interventions outlined throughout this thesis, we propose the following approaches 
to combat challenges associated with neurological conditions and to facilitate improved quality 
of life among those living with the conditions: 
(1) General prevention efforts targeted to those in occupations that expose them to 
occupational chemicals or toxins. The promotion and regulation of safe use of toxic 
substances may include: substitution of toxic materials with less hazardous 
substances, educating professionals on wearing personal protective equipment and 
safe handling and disposal of toxins, ensuring proper ventilation and respiratory 
protection when working with harmful environmental toxins. 
(2) Population health promotion efforts that encourage healthy lifestyles and social habits 
and prevention of risky recreational activities. Public awareness campaigns and 
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educational programs aimed at reducing diabetes mellitus, obesity, cardiovascular 
disease, hypertension, hypercholesterolemia, depression, alcohol abuse and smoking 
need to be strengthened. Health promotion programs that focus on building cognitive 
reserve and mental capacity, increasing physical activity and exercise, encouraging 
mindfulness and optimism, spiritual and wellness activities, social engagement 
including attendance at religious services where applicable and healthy nutritional 
choices, are recommended. 
(3) Secondary prevention and health system design that ensure adequate access and 
quality of care that meet the holistic needs of people living with neurological 
conditions. This includes building capacity by deploying human resources to increase 
access to specialist services especially in rural areas. This may involve a wider study 
of the geographical pockets impacted by long wait times for initial diagnosis. 
Strengthening the capacity of the health system to adopt a coordinated approach to 
care that ensures psychosocial difficulties and caregiver burden are addressed and that 
sustainable long-term care is in place for those individuals whose conditions have so 
far progressed that they are unable to continue to live in the community. Given the 
shortage of neurologists and movement disorder specialists, an integrated model of 
care is necessary for managing neurological conditions. This involves improving self-
management by intentional education and facilitation of patient and caregiver 
involvement in management of their condition; the coordinated provision of care 
including timely referrals to specialists, therapists and social care workers. 
In order to ensure that these recommendations are informed by best practices and will meet the 
needs of the population, future neurological conditions research is important. There is limited 
epidemiological research on neurological conditions as a group in Canada. More research is 
needed on the common modifiable risk factors for varying neurological conditions, so that 
effective population-based prevention efforts can be established. Trend studies that utilize a 
longitudinal design to estimate incidence and prevalence of neurological conditions in the 
Canadian population and within health regions are also needed to help with human health 
resource planning and designing health services that are accessible along the continuum/circle of 
care for those with NC. 
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 Including individuals in institutions and identifying specific unmet health care needs and 
their associations with specific elements of care provided throughout disease progression will be 
helpful to the further strengthening of the health system’s capacity to adequately care for the NC 
population. As well, understanding the role that severity of disease plays in quality of life is key 
to understanding unmet health care needs of patients with NC. Performing studies with larger 
sample sizes and that include a comparison between patients with neurological conditions and 
those without are important for enhancing generalizability of findings on quality of life domains.  
7.3 Conclusion 
The key messages from this research are summarized as follows: 
(1) Toxic occupational exposures, particularly, pesticide exposures are strongly 
associated with the development of PD. Standardized methods of PD diagnosis by 
a neurologist or nurse is important in establishing the relationship between 
exposures and PD outcomes. 
(2) Community-based prevalence of AD/dementia is on the increase across all strata 
of the society, with more men than women living with the condition in the 
community. 
(3) Unmet health care needs significantly reduce patient satisfaction with general 
health care services, hospital and physician services. While emergency care 
received at the hospital decreased the odds of patient satisfaction, there was no 
significant difference in patient satisfaction between primary care physician and 
specialist care among those with neurological conditions. Availability of 
provincial care is important to patient satisfaction with hospital services but not 
with physician services. Not surprisingly, the quality of care received across 
health services predicts the level of neurological patients’ satisfaction with health 
care. 
(4) General life satisfaction, a subjective measure of one’s quality of life  is positively 
predicted by spiritual coping (spiritual values-strength for everyday difficulties) 
and regular attendance at religious services, self-perceived health and self-
perceived mental health. 
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In light of these findings, the final take-away messages for the Canadian public health system are 
(1) a population-based approach is needed in strengthening health promotion and primary 
prevention of neurological conditions, and (2) a coordinated holistic system of care is needed to 
ensure enhanced quality of life among patients with neurological conditions.  
 The completion of this thesis was made possible by the services of the SKY-RDC 
provided through the Canadian Data Research Network Centres of Statistics Canada. We 
appreciate this service and the data that it allows researchers to access to contribute to knowledge 
translation. However, we have included recommendations for improvement of the content of the 
annual surveys and access of the data to researchers.  
 One limitation of the CCHS data was that it did not include information on the 
institutional population and people living in certain remote areas. We were not able to generalize 
our findings to the entire Canadian population. As a result, we recommend to Statistics Canada 
that surveys that include rural, remote and institutional populations be conducted on occasion. 
This is important to further the knowledge acquired through studies similar to this thesis, that 
examines quality of life measures for older Canadians with neurodegenerative chronic 
conditions. 
 In addition, researchers’ access to data and progression of their work may be hindered by 
the need to be physically present to utilize the services of a Data Research Network Centre. As 
such, we recommend utilization of existing technology to augment the security of remote access 
to data as a more flexible approach to researchers. 
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